JP2020079309A - Muscle-enhancing agent - Google Patents
Muscle-enhancing agent Download PDFInfo
- Publication number
- JP2020079309A JP2020079309A JP2020030484A JP2020030484A JP2020079309A JP 2020079309 A JP2020079309 A JP 2020079309A JP 2020030484 A JP2020030484 A JP 2020030484A JP 2020030484 A JP2020030484 A JP 2020030484A JP 2020079309 A JP2020079309 A JP 2020079309A
- Authority
- JP
- Japan
- Prior art keywords
- extract
- muscle
- rice
- active ingredient
- fermented
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000003205 muscle Anatomy 0.000 claims abstract description 57
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 31
- 239000004480 active ingredient Substances 0.000 claims abstract description 30
- 230000004069 differentiation Effects 0.000 claims abstract description 24
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 claims abstract description 15
- 230000006698 induction Effects 0.000 claims abstract description 15
- 229940032091 stigmasterol Drugs 0.000 claims abstract description 13
- 235000016831 stigmasterol Nutrition 0.000 claims abstract description 13
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 claims abstract description 13
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 claims abstract description 12
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 claims abstract description 12
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 claims abstract description 12
- 150000001875 compounds Chemical class 0.000 claims abstract description 12
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 claims abstract description 12
- 150000002305 glucosylceramides Chemical class 0.000 claims abstract description 10
- UPJVQRZPXLZUET-UHFFFAOYSA-N (10R)-3c,5t,8t-Trihydroxy-10r,13c-dimethyl-17c-((1R:4R)-1,4,5-trimethyl-hexen-(2t)-yl)-(9tH,14tH)-Delta6-tetradecahydro-1H-cyclopenta[a]phenanthren Natural products OC12C=CC3(O)CC(O)CCC3(C)C2CCC2(C)C1CCC2C(C)C=CC(C)C(C)C UPJVQRZPXLZUET-UHFFFAOYSA-N 0.000 claims abstract description 7
- 239000004067 bulking agent Substances 0.000 claims abstract description 7
- VXOZCESVZIRHCJ-KGHQQZOUSA-N ergosterol peroxide Chemical compound O1O[C@@]2(C=C3)[C@@H]4CC[C@H]([C@H](C)/C=C/[C@H](C)C(C)C)[C@@]4(C)CC[C@@H]2[C@]2(C)[C@@]13C[C@@H](O)CC2 VXOZCESVZIRHCJ-KGHQQZOUSA-N 0.000 claims abstract description 7
- VXOZCESVZIRHCJ-KYQKSOQPSA-N ergosterol peroxide Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@@H]2[C@]1(C)CC[C@@H]3[C@@]4(C)CC[C@H](O)C[C@@]45OO[C@@]23C=C5 VXOZCESVZIRHCJ-KYQKSOQPSA-N 0.000 claims abstract description 7
- LESGHGUKCRHTCP-UHFFFAOYSA-N ergosteryl peroxide Natural products C1C(OO)CCC2(C)C(CCC3(C(C(C)C=CC(C)C(C)C)CCC33)C)C3=CC=C21 LESGHGUKCRHTCP-UHFFFAOYSA-N 0.000 claims abstract description 7
- PBWOIPCULUXTNY-UHFFFAOYSA-N Sitosterylacetat Natural products C1C=C2CC(OC(C)=O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 PBWOIPCULUXTNY-UHFFFAOYSA-N 0.000 claims abstract description 5
- QXMNTPFFZFYQAI-IMDKZJJXSA-N beta-sitosterol 3-O-beta-D-glucopyranoside Natural products CC[C@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@H](CC[C@]4(C)[C@H]3CC[C@]12C)O[C@@H]5C[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)C(C)C QXMNTPFFZFYQAI-IMDKZJJXSA-N 0.000 claims abstract description 5
- NPJICTMALKLTFW-OFUAXYCQSA-N daucosterol Chemical compound O([C@@H]1CC2=CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CC[C@@H](CC)C(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O NPJICTMALKLTFW-OFUAXYCQSA-N 0.000 claims abstract description 5
- 230000014509 gene expression Effects 0.000 claims description 14
- 238000005728 strengthening Methods 0.000 claims description 6
- 230000003387 muscular Effects 0.000 claims description 4
- 239000000284 extract Substances 0.000 abstract description 95
- 235000007164 Oryza sativa Nutrition 0.000 abstract description 82
- 235000009566 rice Nutrition 0.000 abstract description 80
- 239000002798 polar solvent Substances 0.000 abstract description 16
- 241000209094 Oryza Species 0.000 abstract description 11
- 238000009826 distribution Methods 0.000 abstract description 3
- 240000007594 Oryza sativa Species 0.000 description 76
- 235000013305 food Nutrition 0.000 description 39
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 31
- 239000000203 mixture Substances 0.000 description 23
- -1 fatty acid esters Chemical class 0.000 description 22
- 230000000694 effects Effects 0.000 description 21
- 238000000855 fermentation Methods 0.000 description 20
- 230000004151 fermentation Effects 0.000 description 20
- 239000000047 product Substances 0.000 description 19
- 108090000623 proteins and genes Proteins 0.000 description 18
- 235000018102 proteins Nutrition 0.000 description 17
- 102000004169 proteins and genes Human genes 0.000 description 17
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 16
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 15
- 238000012360 testing method Methods 0.000 description 15
- 235000013402 health food Nutrition 0.000 description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 13
- 235000014113 dietary fatty acids Nutrition 0.000 description 13
- 239000000194 fatty acid Substances 0.000 description 13
- 229930195729 fatty acid Natural products 0.000 description 13
- 238000009472 formulation Methods 0.000 description 13
- 230000036541 health Effects 0.000 description 13
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 13
- 230000002708 enhancing effect Effects 0.000 description 12
- 239000003623 enhancer Substances 0.000 description 11
- 235000019441 ethanol Nutrition 0.000 description 11
- 230000001737 promoting effect Effects 0.000 description 11
- 238000000605 extraction Methods 0.000 description 10
- 239000003921 oil Substances 0.000 description 10
- 235000019198 oils Nutrition 0.000 description 10
- 238000002360 preparation method Methods 0.000 description 10
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- 229940125904 compound 1 Drugs 0.000 description 9
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 8
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 8
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 8
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 8
- 229940125898 compound 5 Drugs 0.000 description 8
- 235000011187 glycerol Nutrition 0.000 description 8
- 239000008187 granular material Substances 0.000 description 8
- 239000000463 material Substances 0.000 description 8
- 235000013372 meat Nutrition 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- 239000000843 powder Substances 0.000 description 8
- MZSAMHOCTRNOIZ-UHFFFAOYSA-N 3-[4-(aminomethyl)-6-(trifluoromethyl)pyridin-2-yl]oxy-N-phenylaniline Chemical compound NCC1=CC(=NC(=C1)C(F)(F)F)OC=1C=C(NC2=CC=CC=C2)C=CC=1 MZSAMHOCTRNOIZ-UHFFFAOYSA-N 0.000 description 7
- 240000006439 Aspergillus oryzae Species 0.000 description 7
- 235000002247 Aspergillus oryzae Nutrition 0.000 description 7
- 102000004218 Insulin-Like Growth Factor I Human genes 0.000 description 7
- 244000269722 Thea sinensis Species 0.000 description 7
- 238000011156 evaluation Methods 0.000 description 7
- 239000002904 solvent Substances 0.000 description 7
- 235000013616 tea Nutrition 0.000 description 7
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- 240000008620 Fagopyrum esculentum Species 0.000 description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 6
- 229920002472 Starch Polymers 0.000 description 6
- 229930006000 Sucrose Natural products 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 6
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 6
- 230000001965 increasing effect Effects 0.000 description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 6
- 239000008101 lactose Substances 0.000 description 6
- 230000004118 muscle contraction Effects 0.000 description 6
- 239000003755 preservative agent Substances 0.000 description 6
- 239000008107 starch Substances 0.000 description 6
- 235000019698 starch Nutrition 0.000 description 6
- 239000005720 sucrose Substances 0.000 description 6
- 235000000346 sugar Nutrition 0.000 description 6
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 6
- 229940088594 vitamin Drugs 0.000 description 6
- 229930003231 vitamin Natural products 0.000 description 6
- 235000013343 vitamin Nutrition 0.000 description 6
- 239000011782 vitamin Substances 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- 102000008186 Collagen Human genes 0.000 description 5
- 108010035532 Collagen Proteins 0.000 description 5
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 5
- 108010010803 Gelatin Proteins 0.000 description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 5
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 5
- 240000008042 Zea mays Species 0.000 description 5
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 5
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 5
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 5
- 241000234314 Zingiber Species 0.000 description 5
- 235000006886 Zingiber officinale Nutrition 0.000 description 5
- 239000003963 antioxidant agent Substances 0.000 description 5
- 235000006708 antioxidants Nutrition 0.000 description 5
- 235000015165 citric acid Nutrition 0.000 description 5
- 229920001436 collagen Polymers 0.000 description 5
- 235000005822 corn Nutrition 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 239000000796 flavoring agent Substances 0.000 description 5
- 235000019634 flavors Nutrition 0.000 description 5
- 239000008273 gelatin Substances 0.000 description 5
- 229920000159 gelatin Polymers 0.000 description 5
- 235000019322 gelatine Nutrition 0.000 description 5
- 235000011852 gelatine desserts Nutrition 0.000 description 5
- 235000008397 ginger Nutrition 0.000 description 5
- 239000008103 glucose Substances 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 239000003550 marker Substances 0.000 description 5
- 210000003098 myoblast Anatomy 0.000 description 5
- 230000035755 proliferation Effects 0.000 description 5
- 239000006188 syrup Substances 0.000 description 5
- 235000020357 syrup Nutrition 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 4
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 4
- 235000009434 Actinidia chinensis Nutrition 0.000 description 4
- 235000009436 Actinidia deliciosa Nutrition 0.000 description 4
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 description 4
- 240000003538 Chamaemelum nobile Species 0.000 description 4
- 235000007866 Chamaemelum nobile Nutrition 0.000 description 4
- 229920001661 Chitosan Polymers 0.000 description 4
- 241000251730 Chondrichthyes Species 0.000 description 4
- 229920002567 Chondroitin Polymers 0.000 description 4
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 4
- 235000003392 Curcuma domestica Nutrition 0.000 description 4
- 244000008991 Curcuma longa Species 0.000 description 4
- 235000002767 Daucus carota Nutrition 0.000 description 4
- 244000000626 Daucus carota Species 0.000 description 4
- 235000016623 Fragaria vesca Nutrition 0.000 description 4
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 4
- 241000233866 Fungi Species 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- 240000005979 Hordeum vulgare Species 0.000 description 4
- 235000007340 Hordeum vulgare Nutrition 0.000 description 4
- 102000010445 Lactoferrin Human genes 0.000 description 4
- 108010063045 Lactoferrin Proteins 0.000 description 4
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 4
- 235000008708 Morus alba Nutrition 0.000 description 4
- 240000000249 Morus alba Species 0.000 description 4
- 240000005561 Musa balbisiana Species 0.000 description 4
- 102000004364 Myogenin Human genes 0.000 description 4
- 108010056785 Myogenin Proteins 0.000 description 4
- 244000183278 Nephelium litchi Species 0.000 description 4
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 4
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 4
- 240000007817 Olea europaea Species 0.000 description 4
- 241000237502 Ostreidae Species 0.000 description 4
- 235000004347 Perilla Nutrition 0.000 description 4
- 244000124853 Perilla frutescens Species 0.000 description 4
- 244000178231 Rosmarinus officinalis Species 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 108010050181 aleurone Proteins 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 235000013793 astaxanthin Nutrition 0.000 description 4
- 229940022405 astaxanthin Drugs 0.000 description 4
- 239000001168 astaxanthin Substances 0.000 description 4
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 description 4
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 4
- 235000021329 brown rice Nutrition 0.000 description 4
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 4
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 4
- 235000005487 catechin Nutrition 0.000 description 4
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 4
- DLGJWSVWTWEWBJ-HGGSSLSASA-N chondroitin Chemical compound CC(O)=N[C@@H]1[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1OC1[C@H](O)[C@H](O)C=C(C(O)=O)O1 DLGJWSVWTWEWBJ-HGGSSLSASA-N 0.000 description 4
- 235000017471 coenzyme Q10 Nutrition 0.000 description 4
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 4
- 239000000512 collagen gel Substances 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 238000012258 culturing Methods 0.000 description 4
- 235000003373 curcuma longa Nutrition 0.000 description 4
- 238000005238 degreasing Methods 0.000 description 4
- 235000013325 dietary fiber Nutrition 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 239000003205 fragrance Substances 0.000 description 4
- 235000020708 ginger extract Nutrition 0.000 description 4
- 229940002508 ginger extract Drugs 0.000 description 4
- 229960002442 glucosamine Drugs 0.000 description 4
- 229910052742 iron Inorganic materials 0.000 description 4
- 229960003284 iron Drugs 0.000 description 4
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 4
- 235000021242 lactoferrin Nutrition 0.000 description 4
- 229940078795 lactoferrin Drugs 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 210000000663 muscle cell Anatomy 0.000 description 4
- 230000037257 muscle growth Effects 0.000 description 4
- 229960003512 nicotinic acid Drugs 0.000 description 4
- 235000001968 nicotinic acid Nutrition 0.000 description 4
- 239000011664 nicotinic acid Substances 0.000 description 4
- CNNRPFQICPFDPO-UHFFFAOYSA-N octacosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCO CNNRPFQICPFDPO-UHFFFAOYSA-N 0.000 description 4
- 229920001542 oligosaccharide Polymers 0.000 description 4
- 150000002482 oligosaccharides Chemical class 0.000 description 4
- 235000020636 oyster Nutrition 0.000 description 4
- 238000005192 partition Methods 0.000 description 4
- 239000000546 pharmaceutical excipient Substances 0.000 description 4
- 239000000049 pigment Substances 0.000 description 4
- 229920000768 polyamine Polymers 0.000 description 4
- 239000013641 positive control Substances 0.000 description 4
- 238000000638 solvent extraction Methods 0.000 description 4
- 229930003802 tocotrienol Natural products 0.000 description 4
- 239000011731 tocotrienol Substances 0.000 description 4
- 235000019148 tocotrienols Nutrition 0.000 description 4
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 4
- 235000013976 turmeric Nutrition 0.000 description 4
- 150000003722 vitamin derivatives Chemical class 0.000 description 4
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 3
- 244000215068 Acacia senegal Species 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 244000298715 Actinidia chinensis Species 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 3
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 3
- 241000167854 Bourreria succulenta Species 0.000 description 3
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 3
- 241000207199 Citrus Species 0.000 description 3
- 235000009917 Crataegus X brevipes Nutrition 0.000 description 3
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 description 3
- 235000009685 Crataegus X maligna Nutrition 0.000 description 3
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 description 3
- 235000009486 Crataegus bullatus Nutrition 0.000 description 3
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 description 3
- 235000009682 Crataegus limnophila Nutrition 0.000 description 3
- 240000000171 Crataegus monogyna Species 0.000 description 3
- 235000004423 Crataegus monogyna Nutrition 0.000 description 3
- 235000002313 Crataegus paludosa Nutrition 0.000 description 3
- 235000009840 Crataegus x incaedua Nutrition 0.000 description 3
- 240000009088 Fragaria x ananassa Species 0.000 description 3
- 235000001637 Ganoderma lucidum Nutrition 0.000 description 3
- 240000008397 Ganoderma lucidum Species 0.000 description 3
- 229920000084 Gum arabic Polymers 0.000 description 3
- 235000015429 Mirabilis expansa Nutrition 0.000 description 3
- 244000294411 Mirabilis expansa Species 0.000 description 3
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 3
- 240000003296 Petasites japonicus Species 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 244000299461 Theobroma cacao Species 0.000 description 3
- 235000010489 acacia gum Nutrition 0.000 description 3
- 239000000205 acacia gum Substances 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- 235000010419 agar Nutrition 0.000 description 3
- 229940076810 beta sitosterol Drugs 0.000 description 3
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 230000010261 cell growth Effects 0.000 description 3
- 230000004663 cell proliferation Effects 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 235000019693 cherries Nutrition 0.000 description 3
- 229950001002 cianidanol Drugs 0.000 description 3
- 235000017803 cinnamon Nutrition 0.000 description 3
- 235000020971 citrus fruits Nutrition 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 239000002552 dosage form Substances 0.000 description 3
- 235000019152 folic acid Nutrition 0.000 description 3
- 229960000304 folic acid Drugs 0.000 description 3
- 239000011724 folic acid Substances 0.000 description 3
- AQLRNQCFQNNMJA-UHFFFAOYSA-N fucoxanthin Natural products CC(=O)OC1CC(C)(C)C(=C=CC(=CC=CC(=CC=CC=C(/C)C=CC=C(/C)C(=O)CC23OC2(C)CC(O)CC3(C)C)C)CO)C(C)(O)C1 AQLRNQCFQNNMJA-UHFFFAOYSA-N 0.000 description 3
- SJWWTRQNNRNTPU-ABBNZJFMSA-N fucoxanthin Chemical compound C[C@@]1(O)C[C@@H](OC(=O)C)CC(C)(C)C1=C=C\C(C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)C(=O)C[C@]1(C(C[C@H](O)C2)(C)C)[C@]2(C)O1 SJWWTRQNNRNTPU-ABBNZJFMSA-N 0.000 description 3
- 229930182470 glycoside Natural products 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- IQZZFVDIZRWADY-UHFFFAOYSA-N isocoumarin Chemical compound C1=CC=C2C(=O)OC=CC2=C1 IQZZFVDIZRWADY-UHFFFAOYSA-N 0.000 description 3
- 239000004310 lactic acid Substances 0.000 description 3
- 235000014655 lactic acid Nutrition 0.000 description 3
- 235000013536 miso Nutrition 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 229940109850 royal jelly Drugs 0.000 description 3
- 235000002020 sage Nutrition 0.000 description 3
- 229950005143 sitosterol Drugs 0.000 description 3
- 235000013555 soy sauce Nutrition 0.000 description 3
- 150000003408 sphingolipids Chemical class 0.000 description 3
- 239000013589 supplement Substances 0.000 description 3
- 239000003826 tablet Substances 0.000 description 3
- 229960003080 taurine Drugs 0.000 description 3
- 235000019154 vitamin C Nutrition 0.000 description 3
- 239000011718 vitamin C Substances 0.000 description 3
- 235000019165 vitamin E Nutrition 0.000 description 3
- 239000011709 vitamin E Substances 0.000 description 3
- 239000011701 zinc Substances 0.000 description 3
- 229910052725 zinc Inorganic materials 0.000 description 3
- PEYUIKBAABKQKQ-AFHBHXEDSA-N (+)-sesamin Chemical compound C1=C2OCOC2=CC([C@H]2OC[C@H]3[C@@H]2CO[C@@H]3C2=CC=C3OCOC3=C2)=C1 PEYUIKBAABKQKQ-AFHBHXEDSA-N 0.000 description 2
- JQWAHKMIYCERGA-UHFFFAOYSA-N (2-nonanoyloxy-3-octadeca-9,12-dienoyloxypropoxy)-[2-(trimethylazaniumyl)ethyl]phosphinate Chemical compound CCCCCCCCC(=O)OC(COP([O-])(=O)CC[N+](C)(C)C)COC(=O)CCCCCCCC=CCC=CCCCCC JQWAHKMIYCERGA-UHFFFAOYSA-N 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 2
- JKQXZKUSFCKOGQ-JLGXGRJMSA-N (3R,3'R)-beta,beta-carotene-3,3'-diol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-JLGXGRJMSA-N 0.000 description 2
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 2
- AGBQKNBQESQNJD-SSDOTTSWSA-N (R)-lipoic acid Chemical compound OC(=O)CCCC[C@@H]1CCSS1 AGBQKNBQESQNJD-SSDOTTSWSA-N 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 2
- GJJVAFUKOBZPCB-ZGRPYONQSA-N (r)-3,4-dihydro-2-methyl-2-(4,8,12-trimethyl-3,7,11-tridecatrienyl)-2h-1-benzopyran-6-ol Chemical class OC1=CC=C2OC(CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)(C)CCC2=C1 GJJVAFUKOBZPCB-ZGRPYONQSA-N 0.000 description 2
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 description 2
- 229940058015 1,3-butylene glycol Drugs 0.000 description 2
- PZNPLUBHRSSFHT-RRHRGVEJSA-N 1-hexadecanoyl-2-octadecanoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCCC(=O)O[C@@H](COP([O-])(=O)OCC[N+](C)(C)C)COC(=O)CCCCCCCCCCCCCCC PZNPLUBHRSSFHT-RRHRGVEJSA-N 0.000 description 2
- 229960002666 1-octacosanol Drugs 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 2
- WVXRAFOPTSTNLL-NKWVEPMBSA-N 2',3'-dideoxyadenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1CC[C@@H](CO)O1 WVXRAFOPTSTNLL-NKWVEPMBSA-N 0.000 description 2
- PWKSKIMOESPYIA-UHFFFAOYSA-N 2-acetamido-3-sulfanylpropanoic acid Chemical compound CC(=O)NC(CS)C(O)=O PWKSKIMOESPYIA-UHFFFAOYSA-N 0.000 description 2
- GJJVAFUKOBZPCB-UHFFFAOYSA-N 2-methyl-2-(4,8,12-trimethyltrideca-3,7,11-trienyl)-3,4-dihydrochromen-6-ol Chemical compound OC1=CC=C2OC(CCC=C(C)CCC=C(C)CCC=C(C)C)(C)CCC2=C1 GJJVAFUKOBZPCB-UHFFFAOYSA-N 0.000 description 2
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 2
- 241000906543 Actaea racemosa Species 0.000 description 2
- 244000251953 Agaricus brunnescens Species 0.000 description 2
- JDLKFOPOAOFWQN-VIFPVBQESA-N Allicin Natural products C=CCS[S@](=O)CC=C JDLKFOPOAOFWQN-VIFPVBQESA-N 0.000 description 2
- 241000234282 Allium Species 0.000 description 2
- 240000006108 Allium ampeloprasum Species 0.000 description 2
- 235000005254 Allium ampeloprasum Nutrition 0.000 description 2
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 2
- 240000002234 Allium sativum Species 0.000 description 2
- 241000583531 Alpinia purpurata Species 0.000 description 2
- 244000144730 Amygdalus persica Species 0.000 description 2
- 244000099147 Ananas comosus Species 0.000 description 2
- 235000007119 Ananas comosus Nutrition 0.000 description 2
- 241000256844 Apis mellifera Species 0.000 description 2
- 235000017060 Arachis glabrata Nutrition 0.000 description 2
- 244000105624 Arachis hypogaea Species 0.000 description 2
- 235000010777 Arachis hypogaea Nutrition 0.000 description 2
- 235000018262 Arachis monticola Nutrition 0.000 description 2
- 241000988895 Aristotelia chilensis Species 0.000 description 2
- 235000016425 Arthrospira platensis Nutrition 0.000 description 2
- 240000002900 Arthrospira platensis Species 0.000 description 2
- 241000228212 Aspergillus Species 0.000 description 2
- 241000228251 Aspergillus phoenicis Species 0.000 description 2
- 241000186000 Bifidobacterium Species 0.000 description 2
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 description 2
- 235000017647 Brassica oleracea var italica Nutrition 0.000 description 2
- 240000003259 Brassica oleracea var. botrytis Species 0.000 description 2
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 2
- 235000009467 Carica papaya Nutrition 0.000 description 2
- 240000006432 Carica papaya Species 0.000 description 2
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 2
- 244000020518 Carthamus tinctorius Species 0.000 description 2
- 235000004032 Centella asiatica Nutrition 0.000 description 2
- 244000146462 Centella asiatica Species 0.000 description 2
- DQFBYFPFKXHELB-UHFFFAOYSA-N Chalcone Natural products C=1C=CC=CC=1C(=O)C=CC1=CC=CC=C1 DQFBYFPFKXHELB-UHFFFAOYSA-N 0.000 description 2
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 2
- 229920002101 Chitin Polymers 0.000 description 2
- 229920001287 Chondroitin sulfate Polymers 0.000 description 2
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 2
- 235000007516 Chrysanthemum Nutrition 0.000 description 2
- 241000132536 Cirsium Species 0.000 description 2
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 2
- 241000951471 Citrus junos Species 0.000 description 2
- 229920002261 Corn starch Polymers 0.000 description 2
- 244000241257 Cucumis melo Species 0.000 description 2
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 2
- 241000371652 Curvularia clavata Species 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- 239000011627 DL-alpha-tocopherol Substances 0.000 description 2
- 235000001815 DL-alpha-tocopherol Nutrition 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
- 244000133098 Echinacea angustifolia Species 0.000 description 2
- 241001632410 Eleutherococcus senticosus Species 0.000 description 2
- 241000195955 Equisetum hyemale Species 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- 229920000855 Fucoidan Polymers 0.000 description 2
- 244000119461 Garcinia xanthochymus Species 0.000 description 2
- 235000000885 Garcinia xanthochymus Nutrition 0.000 description 2
- 239000006000 Garlic extract Substances 0.000 description 2
- 239000009429 Ginkgo biloba extract Substances 0.000 description 2
- 102100031181 Glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 2
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 2
- 244000303040 Glycyrrhiza glabra Species 0.000 description 2
- 241000208251 Gymnema Species 0.000 description 2
- 241000120595 Haloragis Species 0.000 description 2
- 235000005206 Hibiscus Nutrition 0.000 description 2
- 235000007185 Hibiscus lunariifolius Nutrition 0.000 description 2
- 244000284380 Hibiscus rosa sinensis Species 0.000 description 2
- 235000017309 Hypericum perforatum Nutrition 0.000 description 2
- 244000141009 Hypericum perforatum Species 0.000 description 2
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 2
- 240000007049 Juglans regia Species 0.000 description 2
- 235000009496 Juglans regia Nutrition 0.000 description 2
- 239000002211 L-ascorbic acid Substances 0.000 description 2
- 235000000069 L-ascorbic acid Nutrition 0.000 description 2
- SXZYCXMUPBBULW-SKNVOMKLSA-N L-gulono-1,4-lactone Chemical compound OC[C@H](O)[C@H]1OC(=O)[C@@H](O)[C@H]1O SXZYCXMUPBBULW-SKNVOMKLSA-N 0.000 description 2
- 235000017858 Laurus nobilis Nutrition 0.000 description 2
- 244000165082 Lavanda vera Species 0.000 description 2
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 2
- 240000000599 Lentinula edodes Species 0.000 description 2
- 240000000759 Lepidium meyenii Species 0.000 description 2
- 235000000421 Lepidium meyenii Nutrition 0.000 description 2
- 235000004431 Linum usitatissimum Nutrition 0.000 description 2
- 240000006240 Linum usitatissimum Species 0.000 description 2
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 2
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 2
- 238000000134 MTT assay Methods 0.000 description 2
- 231100000002 MTT assay Toxicity 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 235000014837 Malpighia glabra Nutrition 0.000 description 2
- 240000003394 Malpighia glabra Species 0.000 description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 2
- 235000009811 Momordica charantia Nutrition 0.000 description 2
- 244000302512 Momordica charantia Species 0.000 description 2
- 244000131360 Morinda citrifolia Species 0.000 description 2
- 235000003805 Musa ABB Group Nutrition 0.000 description 2
- 235000018290 Musa x paradisiaca Nutrition 0.000 description 2
- 240000001307 Myosotis scorpioides Species 0.000 description 2
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 2
- 235000002725 Olea europaea Nutrition 0.000 description 2
- 235000007189 Oryza longistaminata Nutrition 0.000 description 2
- 235000011925 Passiflora alata Nutrition 0.000 description 2
- 235000000370 Passiflora edulis Nutrition 0.000 description 2
- 235000011922 Passiflora incarnata Nutrition 0.000 description 2
- 240000002690 Passiflora mixta Species 0.000 description 2
- 235000013750 Passiflora mixta Nutrition 0.000 description 2
- 235000013731 Passiflora van volxemii Nutrition 0.000 description 2
- 235000003823 Petasites japonicus Nutrition 0.000 description 2
- 241001529469 Phoca groenlandica Species 0.000 description 2
- 235000015266 Plantago major Nutrition 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 241000241413 Propolis Species 0.000 description 2
- 235000009827 Prunus armeniaca Nutrition 0.000 description 2
- 244000018633 Prunus armeniaca Species 0.000 description 2
- 244000141353 Prunus domestica Species 0.000 description 2
- 235000006040 Prunus persica var persica Nutrition 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 description 2
- 244000299790 Rheum rhabarbarum Species 0.000 description 2
- 235000009411 Rheum rhabarbarum Nutrition 0.000 description 2
- 240000007651 Rubus glaucus Species 0.000 description 2
- 235000011034 Rubus glaucus Nutrition 0.000 description 2
- 235000009122 Rubus idaeus Nutrition 0.000 description 2
- 241000545263 Salacia <hydroid> Species 0.000 description 2
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 2
- 240000006661 Serenoa repens Species 0.000 description 2
- 235000005318 Serenoa repens Nutrition 0.000 description 2
- 241000533293 Sesbania emerus Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 244000062793 Sorghum vulgare Species 0.000 description 2
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- 244000223014 Syzygium aromaticum Species 0.000 description 2
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 2
- 240000001949 Taraxacum officinale Species 0.000 description 2
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- 235000005212 Terminalia tomentosa Nutrition 0.000 description 2
- 244000125380 Terminalia tomentosa Species 0.000 description 2
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 2
- 235000009470 Theobroma cacao Nutrition 0.000 description 2
- 235000011941 Tilia x europaea Nutrition 0.000 description 2
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 description 2
- 241000209140 Triticum Species 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 2
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 2
- 235000012545 Vaccinium macrocarpon Nutrition 0.000 description 2
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 2
- 244000078534 Vaccinium myrtillus Species 0.000 description 2
- 235000002118 Vaccinium oxycoccus Nutrition 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- JKQXZKUSFCKOGQ-LQFQNGICSA-N Z-zeaxanthin Natural products C([C@H](O)CC=1C)C(C)(C)C=1C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-LQFQNGICSA-N 0.000 description 2
- QOPRSMDTRDMBNK-RNUUUQFGSA-N Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C QOPRSMDTRDMBNK-RNUUUQFGSA-N 0.000 description 2
- 240000008866 Ziziphus nummularia Species 0.000 description 2
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 2
- JKQXZKUSFCKOGQ-LOFNIBRQSA-N all-trans-Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C JKQXZKUSFCKOGQ-LOFNIBRQSA-N 0.000 description 2
- 150000004347 all-trans-retinol derivatives Chemical class 0.000 description 2
- JDLKFOPOAOFWQN-UHFFFAOYSA-N allicin Chemical compound C=CCSS(=O)CC=C JDLKFOPOAOFWQN-UHFFFAOYSA-N 0.000 description 2
- 235000010081 allicin Nutrition 0.000 description 2
- AGBQKNBQESQNJD-UHFFFAOYSA-N alpha-Lipoic acid Natural products OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
- 230000006907 apoptotic process Effects 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 229940069780 barley extract Drugs 0.000 description 2
- 229940069765 bean extract Drugs 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 229940055416 blueberry extract Drugs 0.000 description 2
- 235000019216 blueberry extract Nutrition 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 2
- 235000001436 butterbur Nutrition 0.000 description 2
- 229960001948 caffeine Drugs 0.000 description 2
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 2
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 2
- 229960002079 calcium pantothenate Drugs 0.000 description 2
- 159000000007 calcium salts Chemical class 0.000 description 2
- 229960002504 capsaicin Drugs 0.000 description 2
- 235000017663 capsaicin Nutrition 0.000 description 2
- 235000010418 carrageenan Nutrition 0.000 description 2
- 239000000679 carrageenan Substances 0.000 description 2
- 229920001525 carrageenan Polymers 0.000 description 2
- 229940113118 carrageenan Drugs 0.000 description 2
- 210000000845 cartilage Anatomy 0.000 description 2
- 239000005018 casein Substances 0.000 description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 2
- 235000021240 caseins Nutrition 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 235000010980 cellulose Nutrition 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 229940106189 ceramide Drugs 0.000 description 2
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 2
- 235000005513 chalcones Nutrition 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 229960001231 choline Drugs 0.000 description 2
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 2
- 229940059329 chondroitin sulfate Drugs 0.000 description 2
- 229910052804 chromium Inorganic materials 0.000 description 2
- 239000011651 chromium Substances 0.000 description 2
- 235000012721 chromium Nutrition 0.000 description 2
- 235000005301 cimicifuga racemosa Nutrition 0.000 description 2
- 229940110767 coenzyme Q10 Drugs 0.000 description 2
- 238000013329 compounding Methods 0.000 description 2
- 229920002770 condensed tannin Polymers 0.000 description 2
- 230000008602 contraction Effects 0.000 description 2
- 239000008120 corn starch Substances 0.000 description 2
- 238000012937 correction Methods 0.000 description 2
- 235000004634 cranberry Nutrition 0.000 description 2
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 235000014134 echinacea Nutrition 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 239000008157 edible vegetable oil Substances 0.000 description 2
- 230000002900 effect on cell Effects 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- PEYUIKBAABKQKQ-UHFFFAOYSA-N epiasarinin Natural products C1=C2OCOC2=CC(C2OCC3C2COC3C2=CC=C3OCOC3=C2)=C1 PEYUIKBAABKQKQ-UHFFFAOYSA-N 0.000 description 2
- 229940045761 evening primrose extract Drugs 0.000 description 2
- 235000008524 evening primrose extract Nutrition 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000013312 flour Nutrition 0.000 description 2
- 230000037406 food intake Effects 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 235000004611 garlic Nutrition 0.000 description 2
- 235000020706 garlic extract Nutrition 0.000 description 2
- 235000020686 ginkgo biloba extract Nutrition 0.000 description 2
- 229940068052 ginkgo biloba extract Drugs 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 2
- 150000003278 haem Chemical class 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 235000012907 honey Nutrition 0.000 description 2
- 229920002674 hyaluronan Polymers 0.000 description 2
- 229960003160 hyaluronic acid Drugs 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 2
- 235000008696 isoflavones Nutrition 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 239000001102 lavandula vera Substances 0.000 description 2
- 235000018219 lavender Nutrition 0.000 description 2
- 239000000787 lecithin Substances 0.000 description 2
- 229940067606 lecithin Drugs 0.000 description 2
- 235000010445 lecithin Nutrition 0.000 description 2
- 235000012902 lepidium meyenii Nutrition 0.000 description 2
- 229930013686 lignan Natural products 0.000 description 2
- 150000005692 lignans Chemical class 0.000 description 2
- 235000009408 lignans Nutrition 0.000 description 2
- 239000004571 lime Substances 0.000 description 2
- 229940114371 lingonberry extract Drugs 0.000 description 2
- 235000019136 lipoic acid Nutrition 0.000 description 2
- 238000000622 liquid--liquid extraction Methods 0.000 description 2
- 235000012680 lutein Nutrition 0.000 description 2
- 229960005375 lutein Drugs 0.000 description 2
- 239000001656 lutein Substances 0.000 description 2
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 2
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 2
- 235000012661 lycopene Nutrition 0.000 description 2
- 229960004999 lycopene Drugs 0.000 description 2
- 239000001751 lycopene Substances 0.000 description 2
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 235000001055 magnesium Nutrition 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 239000001630 malic acid Substances 0.000 description 2
- 235000011090 malic acid Nutrition 0.000 description 2
- 230000035800 maturation Effects 0.000 description 2
- 150000004667 medium chain fatty acids Chemical class 0.000 description 2
- 108020004999 messenger RNA Proteins 0.000 description 2
- 239000000401 methanolic extract Substances 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 235000019713 millet Nutrition 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 210000000107 myocyte Anatomy 0.000 description 2
- 229940086319 nattokinase Drugs 0.000 description 2
- 108010073682 nattokinase Proteins 0.000 description 2
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 2
- 235000005152 nicotinamide Nutrition 0.000 description 2
- 239000011570 nicotinamide Substances 0.000 description 2
- 235000017524 noni Nutrition 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 229940055726 pantothenic acid Drugs 0.000 description 2
- 235000019161 pantothenic acid Nutrition 0.000 description 2
- 239000011713 pantothenic acid Substances 0.000 description 2
- 235000020232 peanut Nutrition 0.000 description 2
- 239000001814 pectin Substances 0.000 description 2
- 235000010987 pectin Nutrition 0.000 description 2
- 229920001277 pectin Polymers 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 229940068065 phytosterols Drugs 0.000 description 2
- 235000018192 pine bark supplement Nutrition 0.000 description 2
- 210000002826 placenta Anatomy 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 235000007686 potassium Nutrition 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 230000003449 preventive effect Effects 0.000 description 2
- 229940069949 propolis Drugs 0.000 description 2
- 235000013772 propylene glycol Nutrition 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 229940106796 pycnogenol Drugs 0.000 description 2
- 235000020095 red wine Nutrition 0.000 description 2
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 2
- 235000021283 resveratrol Nutrition 0.000 description 2
- 229940016667 resveratrol Drugs 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000010018 saw palmetto extract Substances 0.000 description 2
- 239000011669 selenium Substances 0.000 description 2
- 229910052711 selenium Inorganic materials 0.000 description 2
- 235000011649 selenium Nutrition 0.000 description 2
- 239000008159 sesame oil Substances 0.000 description 2
- 235000011803 sesame oil Nutrition 0.000 description 2
- VRMHCMWQHAXTOR-CMOCDZPBSA-N sesamin Natural products C1=C2OCOC2=CC([C@@H]2OC[C@@]3(C)[C@H](C=4C=C5OCOC5=CC=4)OC[C@]32C)=C1 VRMHCMWQHAXTOR-CMOCDZPBSA-N 0.000 description 2
- 239000004320 sodium erythorbate Substances 0.000 description 2
- 235000010352 sodium erythorbate Nutrition 0.000 description 2
- RBWSWDPRDBEWCR-RKJRWTFHSA-N sodium;(2r)-2-[(2r)-3,4-dihydroxy-5-oxo-2h-furan-2-yl]-2-hydroxyethanolate Chemical compound [Na+].[O-]C[C@@H](O)[C@H]1OC(=O)C(O)=C1O RBWSWDPRDBEWCR-RKJRWTFHSA-N 0.000 description 2
- 235000021055 solid food Nutrition 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 235000010356 sorbitol Nutrition 0.000 description 2
- 235000020712 soy bean extract Nutrition 0.000 description 2
- 235000012424 soybean oil Nutrition 0.000 description 2
- 239000003549 soybean oil Substances 0.000 description 2
- 239000008347 soybean phospholipid Substances 0.000 description 2
- 229940082787 spirulina Drugs 0.000 description 2
- 229940031439 squalene Drugs 0.000 description 2
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 2
- 229940013618 stevioside Drugs 0.000 description 2
- 235000019202 steviosides Nutrition 0.000 description 2
- 238000012916 structural analysis Methods 0.000 description 2
- 239000000829 suppository Substances 0.000 description 2
- 229920001864 tannin Polymers 0.000 description 2
- 235000018553 tannin Nutrition 0.000 description 2
- 239000001648 tannin Substances 0.000 description 2
- 239000011975 tartaric acid Substances 0.000 description 2
- 235000002906 tartaric acid Nutrition 0.000 description 2
- 229960002663 thioctic acid Drugs 0.000 description 2
- 229960000984 tocofersolan Drugs 0.000 description 2
- 229940068778 tocotrienols Drugs 0.000 description 2
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 2
- 229940035936 ubiquinone Drugs 0.000 description 2
- 229940116269 uric acid Drugs 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- 239000000052 vinegar Substances 0.000 description 2
- 235000021419 vinegar Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 235000020234 walnut Nutrition 0.000 description 2
- 239000010497 wheat germ oil Substances 0.000 description 2
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 2
- 235000013618 yogurt Nutrition 0.000 description 2
- 235000010930 zeaxanthin Nutrition 0.000 description 2
- 229940043269 zeaxanthin Drugs 0.000 description 2
- 239000001775 zeaxanthin Substances 0.000 description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- PJVXUVWGSCCGHT-ZPYZYFCMSA-N (2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal;(3s,4r,5r)-1,3,4,5,6-pentahydroxyhexan-2-one Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O.OC[C@@H](O)[C@@H](O)[C@H](O)C(=O)CO PJVXUVWGSCCGHT-ZPYZYFCMSA-N 0.000 description 1
- XBZYWSMVVKYHQN-MYPRUECHSA-N (4as,6as,6br,8ar,9r,10s,12ar,12br,14bs)-10-hydroxy-2,2,6a,6b,9,12a-hexamethyl-9-[(sulfooxy)methyl]-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylic acid Chemical compound C1C[C@H](O)[C@@](C)(COS(O)(=O)=O)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C XBZYWSMVVKYHQN-MYPRUECHSA-N 0.000 description 1
- MIDXCONKKJTLDX-UHFFFAOYSA-N 3,5-dimethylcyclopentane-1,2-dione Chemical compound CC1CC(C)C(=O)C1=O MIDXCONKKJTLDX-UHFFFAOYSA-N 0.000 description 1
- GOLORTLGFDVFDW-UHFFFAOYSA-N 3-(1h-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one Chemical compound C1=CC=C2NC(C3=CC4=CC=C(C=C4OC3=O)N(CC)CC)=NC2=C1 GOLORTLGFDVFDW-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- BBTIMXAYZRWPNG-UHFFFAOYSA-N 3beta,Delta4-stigmasten-3-ol Natural products C1CC2=CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 BBTIMXAYZRWPNG-UHFFFAOYSA-N 0.000 description 1
- 244000298697 Actinidia deliciosa Species 0.000 description 1
- 241000962514 Alosa chrysochloris Species 0.000 description 1
- 241001513093 Aspergillus awamori Species 0.000 description 1
- 241000122821 Aspergillus kawachii Species 0.000 description 1
- 241000131386 Aspergillus sojae Species 0.000 description 1
- 235000021537 Beetroot Nutrition 0.000 description 1
- 235000016068 Berberis vulgaris Nutrition 0.000 description 1
- 241000335053 Beta vulgaris Species 0.000 description 1
- 235000006506 Brasenia schreberi Nutrition 0.000 description 1
- 244000267222 Brasenia schreberi Species 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000754798 Calophyllum brasiliense Species 0.000 description 1
- SGNBVLSWZMBQTH-FGAXOLDCSA-N Campesterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@H](C(C)C)C)C)CC4)CC3)CC=2)CC1 SGNBVLSWZMBQTH-FGAXOLDCSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 240000005250 Chrysanthemum indicum Species 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 241001672694 Citrus reticulata Species 0.000 description 1
- 241000555678 Citrus unshiu Species 0.000 description 1
- 240000007154 Coffea arabica Species 0.000 description 1
- 241000209205 Coix Species 0.000 description 1
- 241000254173 Coleoptera Species 0.000 description 1
- 229930182843 D-Lactic acid Natural products 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UWTATZPHSA-N D-lactic acid Chemical compound C[C@@H](O)C(O)=O JVTAAEKCZFNVCJ-UWTATZPHSA-N 0.000 description 1
- SBJKKFFYIZUCET-JLAZNSOCSA-N Dehydro-L-ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(=O)C1=O SBJKKFFYIZUCET-JLAZNSOCSA-N 0.000 description 1
- 206010012438 Dermatitis atopic Diseases 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- 244000307700 Fragaria vesca Species 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- BTEISVKTSQLKST-UHFFFAOYSA-N Haliclonasterol Natural products CC(C=CC(C)C(C)(C)C)C1CCC2C3=CC=C4CC(O)CCC4(C)C3CCC12C BTEISVKTSQLKST-UHFFFAOYSA-N 0.000 description 1
- 101000599951 Homo sapiens Insulin-like growth factor I Proteins 0.000 description 1
- 244000267823 Hydrangea macrophylla Species 0.000 description 1
- 235000014486 Hydrangea macrophylla Nutrition 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 102100037852 Insulin-like growth factor I Human genes 0.000 description 1
- 240000008415 Lactuca sativa Species 0.000 description 1
- 241000270711 Malaclemys terrapin Species 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010028311 Muscle hypertrophy Diseases 0.000 description 1
- 102000003505 Myosin Human genes 0.000 description 1
- 108060008487 Myosin Proteins 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 241000219925 Oenothera Species 0.000 description 1
- 235000004496 Oenothera biennis Nutrition 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 244000134552 Plantago ovata Species 0.000 description 1
- 235000003421 Plantago ovata Nutrition 0.000 description 1
- 241000222351 Pleurotus cornucopiae Species 0.000 description 1
- 239000009223 Psyllium Substances 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 235000019774 Rice Bran oil Nutrition 0.000 description 1
- 208000019802 Sexually transmitted disease Diseases 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 235000006468 Thea sinensis Nutrition 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 241001482311 Trionychidae Species 0.000 description 1
- 241000001727 Tropicoporus linteus Species 0.000 description 1
- 240000001717 Vaccinium macrocarpon Species 0.000 description 1
- 244000291414 Vaccinium oxycoccus Species 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 235000020054 awamori Nutrition 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- QADVIPISOOQJMJ-WLKYTNTRSA-N beta-stigmasterol Natural products CCC(CC)C=C[C@@H](C)[C@H]1CC[C@@H]2[C@@H]1CC[C@H]3[C@H]2CC=C4C[C@@H](O)CC[C@]34C QADVIPISOOQJMJ-WLKYTNTRSA-N 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 235000019537 butterbur extract Nutrition 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- KRPUUUJWTZKSOK-YDALLXLXSA-L calcium (4S)-4-[[4-[(2-amino-4-oxidopteridin-6-yl)methylamino]benzoyl]amino]-5-hydroxy-5-oxopentanoate Chemical compound [Ca++].Nc1nc([O-])c2nc(CNc3ccc(cc3)C(=O)N[C@@H](CCC([O-])=O)C(O)=O)cnc2n1 KRPUUUJWTZKSOK-YDALLXLXSA-L 0.000 description 1
- SGNBVLSWZMBQTH-PODYLUTMSA-N campesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](C)C(C)C)[C@@]1(C)CC2 SGNBVLSWZMBQTH-PODYLUTMSA-N 0.000 description 1
- 235000000431 campesterol Nutrition 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 235000013736 caramel Nutrition 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 150000001765 catechin Chemical class 0.000 description 1
- 150000001789 chalcones Chemical class 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- 235000020639 clam Nutrition 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 235000016213 coffee Nutrition 0.000 description 1
- 235000013353 coffee beverage Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 229940126214 compound 3 Drugs 0.000 description 1
- 235000014510 cooky Nutrition 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 235000021552 granulated sugar Nutrition 0.000 description 1
- 229940087559 grape seed Drugs 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- JEGUKCSWCFPDGT-UHFFFAOYSA-N h2o hydrate Chemical compound O.O JEGUKCSWCFPDGT-UHFFFAOYSA-N 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 1
- 150000002515 isoflavone derivatives Chemical class 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 235000011477 liquorice Nutrition 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 230000012042 muscle hypertrophy Effects 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 235000020333 oolong tea Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 235000002378 plant sterols Nutrition 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- 238000007517 polishing process Methods 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229920003124 powdered cellulose Polymers 0.000 description 1
- 235000019814 powdered cellulose Nutrition 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 229940070687 psyllium Drugs 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 239000008165 rice bran oil Substances 0.000 description 1
- 235000019992 sake Nutrition 0.000 description 1
- 235000012045 salad Nutrition 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 235000020083 shōchū Nutrition 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 235000014214 soft drink Nutrition 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 235000011496 sports drink Nutrition 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- HCXVJBMSMIARIN-UHFFFAOYSA-N stigmasterol Chemical compound C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 HCXVJBMSMIARIN-UHFFFAOYSA-N 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000000194 supercritical-fluid extraction Methods 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000012929 tonicity agent Substances 0.000 description 1
- DQFBYFPFKXHELB-VAWYXSNFSA-N trans-chalcone Chemical compound C=1C=CC=CC=1C(=O)\C=C\C1=CC=CC=C1 DQFBYFPFKXHELB-VAWYXSNFSA-N 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
Abstract
Description
本発明は新規な成分を有効成分とする筋肉増強剤に関する。本発明は、飲食品(健康食品、特定保健用食品、機能性表示食品)、医薬部外品、医薬品等に広く利用することができる。 The present invention relates to a muscle enhancing agent containing a novel ingredient as an active ingredient. INDUSTRIAL APPLICABILITY The present invention can be widely used for foods and drinks (health foods, foods for specified health uses, foods with functional claims), quasi drugs, pharmaceuticals, and the like.
麹菌(Aspergillus)は日本において古くから日本酒や味噌、醤油の製造に用いられており、我々の生活に必要不可欠な菌である。これらの発酵物は単なる食品だけでなく、機能性を有する食品として注目されており、発酵に伴って様々な生理活性物質が新たに産生する可能性がある。 Aspergillus has been used for a long time in Japan for the production of sake, miso and soy sauce, and is an essential bacterium in our daily lives. These fermented products are attracting attention not only as simple foods but also as functional foods, and there is a possibility that various physiologically active substances will be newly produced during fermentation.
一方、スフィンゴ脂質は、皮膚の保湿効果、水分調節、弾力性保持、表面保護(バリヤー効果)、コラーゲン保護、酸化防止(ビタミンCやEの安定化)等の機能が知られており、化粧品の分野で広く用いられている。また、最近では、スフィンゴ脂質の作用として、外界から体内への抗原の侵入を阻止し、アトピー性皮膚炎を抑えることが明らかになり、医薬品としての開発も進められている。 On the other hand, sphingolipids are known to have functions such as skin moisturizing effect, water regulation, elasticity retention, surface protection (barrier effect), collagen protection, and antioxidant (stabilization of vitamins C and E). Widely used in the field. In addition, recently, as a function of sphingolipids, it has been clarified that the invasion of antigens from the outside to the body is suppressed and atopic dermatitis is suppressed, and the development as a pharmaceutical is being promoted.
米から、スフィンゴ脂質含有組成物の製造方法としては、例えば、米糠油の製造工程で得られるガム質を、有機溶剤により脱脂し、この脱脂物を水またはアルコール抽出する方法が知られている(特許文献1)。 As a method for producing a sphingolipid-containing composition from rice, for example, a method is known in which the gum obtained in the production process of rice bran oil is defatted with an organic solvent, and the defatted product is extracted with water or alcohol ( Patent Document 1).
一方、フィトステロールの摂取により血中コレステロールが低下することが知られている。フィトステロールは、例えばトウモロコシ、豆又は他の植物油等の植物性油に少量見出される植物ステロール類であり、それらは遊離のステロール、脂肪酸エステル及びグリコシドとして生じる。フィトステロールは構造的にコレステロールに類似し、主要な差異はそれらの側鎖の炭素骨格に生じる。多くの異なったフィトステロール構造が、天然に見出されている。最も一般的なものは、カンペステロール、ベータ−シトステロール及びスティグマステロールである。特に、スティグマステロール(stigmasterol)は血中のコレステロール低下作用が著しい(非特許文献1)。 On the other hand, it is known that ingestion of phytosterol lowers blood cholesterol. Phytosterols are plant sterols found in small amounts in vegetable oils such as corn, beans or other vegetable oils, which occur as free sterols, fatty acid esters and glycosides. Phytosterols are structurally similar to cholesterol, with the major differences occurring in the carbon backbone of their side chains. Many different phytosterol structures are found in nature. The most common are campesterol, beta-sitosterol and stigmasterol. In particular, stigmasterol has a remarkable cholesterol lowering effect in blood (Non-patent Document 1).
また、特開2005−73502号公報(特許文献2)には、コウタケを抽出して得られるコウタケ抽出物からなるアポトーシス誘導能を有する食品又は食品素材が記載されている。また同公報には、このコウタケ抽出物ががんの抑制、予防効果を示すこと、及び、アポトーシス誘導能を有する食品又は食品素材がコウタケ由来のエルゴステロールパーオキサイドからなるものであることが記載されている。 In addition, Japanese Patent Laid-Open No. 2005-73502 (Patent Document 2) describes a food or food material having an apoptosis-inducing ability, which comprises a mushroom extract obtained by extracting a mushroom. In addition, the same publication describes that this extract of mushrooms exhibits cancer suppressing and preventive effects, and that the food or food material having an apoptosis-inducing ability consists of ergosterol peroxide derived from mushrooms. ing.
一方、生活習慣病から派生する疾患を総合的に予防、治療する目的で下記の問題解決を試
みた。既に桑幹粉末に桑葉粉末以上の血糖降下作用(特願2011−90489)と共に
特異的にケルセチン、クロロゲン酸を多量含有するポリフェノール類に長寿遺伝子の活性
化を来たすレスベラトロールを発見した。さらに血管漏弱性疾患に起因する出血に強力な
止血作用を示すβ−シトステロール配糖体を多量含有しているオオマツヨイグサ粉末が高
血糖、高血圧および高脂血症などの生活習慣病に起因する出血性疾患に対する総括的な予
防効果を有することが知られている。
On the other hand, the following problems were tried for the purpose of comprehensively preventing and treating diseases derived from lifestyle-related diseases. We have already discovered resveratrol which activates the longevity gene in polyphenols containing a large amount of quercetin and chlorogenic acid in addition to the hypoglycemic action of mulberry stem powder over that of mulberry leaf powder (Japanese Patent Application No. 2011-90489). Furthermore, evening primrose powder, which contains a large amount of β-sitosterol glycoside that has a strong hemostatic effect on bleeding caused by vascular leaky disease, is a bleeding caused by lifestyle-related diseases such as hyperglycemia, hypertension and hyperlipidemia. It is known to have a comprehensive preventive effect against sexually transmitted diseases.
このような背景の下、本発明者は、米糠及び米胚芽を発酵させることにより得られるグルコシルセラミド、スティグマステロール、エルゴステロールパーオキサイド、及びβ−シトステロール配糖体に筋肉増強作用を有することを見出し、本発明を完成させた。
即ち、本発明は新規な筋肉増強剤を提供することを目的とする。
Under such a background, the present inventor has found that glucosylceramide, stigmasterol, ergosterol peroxide, and β-sitosterol glycoside obtained by fermenting rice bran and rice germ have a muscle-enhancing effect. The present invention has been completed.
That is, an object of the present invention is to provide a new muscle enhancing agent.
上記課題を解決するための本発明の技術的特徴は以下のとおりである。
1.米糠及び/又は米胚芽を発酵させて発酵物を得て、その後、前記発酵米物を極性溶媒で抽出した発酵抽出物を有効成分とする筋分化誘導促進剤。
2.上記1.に記載された上記発酵抽出物を極性溶媒で分配した分配物を有効成分とする筋分化誘導促進剤。
3.スティグマステロール、エルゴステロールパーオキサイド、β-シトステロールグルコシド、グルコシルセラミドのうちの少なくとも1種の化合物を有効成分とする筋分化誘導促進剤。
4.米糠及び/又は米胚芽を発酵させて発酵物を得て、その後、前記発酵米物を極性溶媒で抽出した発酵抽出物を有効成分とする筋肉増量剤。
5.上記4.に記載された上記発酵抽出物を極性溶媒で分配した分配物を有効成分とする筋肉増量剤。
6.スティグマステロールを有効成分とする筋肉増量剤。
7.米糠及び/又は米胚芽を発酵させて発酵物を得て、その後、前記発酵米物を極性溶媒で抽出した発酵抽出物を有効成分とする筋肉増量遺伝子発現促進剤。
8.上記7.に記載された上記発酵抽出物を極性溶媒で分配した分配物を有効成分とする筋肉増量遺伝子発現促進剤。
9.スティグマステロール及びグルコシルセラミドのうちの少なくとも1種を有効成分とする筋肉増量遺伝子発現促進剤。
10.米糠及び/又は米胚芽を発酵させて発酵物を得て、その後、前記発酵米物を極性溶媒で抽出した発酵抽出物を有効成分とする筋収縮力向上剤。
11.上記10.に記載された上記発酵抽出物を極性溶媒で分配した分配物を有効成分とする筋収縮力向上剤。
12.グルコシルセラミドを有効成分とする筋収縮力向上剤。
13.上記1.〜12.の剤を有効成分とする筋肉増強剤。
The technical features of the present invention for solving the above problems are as follows.
1. A muscle differentiation induction promoter comprising a fermented extract obtained by fermenting rice bran and/or rice germ to obtain a fermented product, and then extracting the fermented rice product with a polar solvent.
2. Above 1. An agent for promoting muscle differentiation induction, which comprises, as an active ingredient, a partition product obtained by partitioning the fermentation extract described in 1. in a polar solvent.
3. A muscle differentiation induction promoter containing as an active ingredient at least one compound selected from stigmasterol, ergosterol peroxide, β-sitosterol glucoside, and glucosylceramide.
4. A muscle bulking agent comprising a fermented extract obtained by fermenting rice bran and/or rice germ to obtain a fermented product, and then extracting the fermented rice product with a polar solvent.
5. Above 4. A muscle bulking agent comprising a partition product obtained by partitioning the fermentation extract described above in a polar solvent as an active ingredient.
6. A muscle bulking agent containing stigmasterol as an active ingredient.
7. A muscle mass gene expression promoter comprising a fermented extract obtained by fermenting rice bran and/or rice germ to obtain a fermented product, and then extracting the fermented rice product with a polar solvent.
8. Above 7. A muscle mass gene expression promoter comprising the partition product obtained by partitioning the above-mentioned fermentation extract as described in 1. in a polar solvent as an active ingredient.
9. A muscle mass gene expression promoter comprising at least one of stigmasterol and glucosylceramide as an active ingredient.
10. A muscle contraction improving agent comprising a fermented extract obtained by fermenting rice bran and/or rice germ to obtain a fermented product, and then extracting the fermented rice product with a polar solvent.
11. The above 10. An agent for improving muscle contraction force, which comprises as an active ingredient a partition product obtained by partitioning the fermentation extract described in 1. in a polar solvent.
12. A muscular contractile strength improving agent containing glucosylceramide as an active ingredient.
13. Above 1. ~12. A muscle strengthening agent containing the above agent as an active ingredient.
以下に本発明を詳細に説明する。
本発明は、米糠及び/又は米胚芽を発酵させて発酵物を得て、その後、前記発酵米物を極性溶媒で抽出した発酵抽出物を有効成分とすることを特徴とする。
The present invention will be described in detail below.
The present invention is characterized by fermenting rice bran and/or rice germ to obtain a fermented product, and then using the fermented extract obtained by extracting the fermented rice product with a polar solvent as an active ingredient.
「米糠及び/又は米胚芽」には、玄米の精米工程で生じる生糠を用いるとよい。玄米は、果皮,種皮,胚乳および胚芽からなり、胚乳組織の外層には糊粉層という薄い層がある。
精米が進むに従って,果皮、種皮だけでなく、糊粉層までが米糠(生糠)として排除される。必要に応じて、果皮、種皮、米胚芽または糊粉の混合物を用いるか、果皮、種皮、米胚芽または糊粉のいずれかを分離したものを用いることができる。
For the "rice bran and/or rice germ", raw bran produced in the rice polishing process of brown rice may be used. Brown rice consists of pericarp, seed coat, endosperm and germ, and the outer layer of endosperm tissue has a thin layer called aleurone layer.
As rice polishing progresses, not only the pericarp and seed coat but also the aleurone layer are eliminated as rice bran (raw bran). If necessary, a mixture of pericarp, seed coat, rice germ or aleurone can be used, or one obtained by separating either pericarp, seed coat, rice germ or aleurone can be used.
また、上記米糠及び/又は米胚芽は脱脂したものと使用することが好ましい。より高濃度の有効成分を含有する組成物を得ることができるからである。この脱脂の方法は特に限定されず、
このとき、好ましい脱脂用溶媒としては、n−ヘキサン、アセトン等が挙げられる。特に、脱脂用溶媒としてn−ヘキサンを用いることが好ましい。抽出油分を食用油として使用し得るとともに、米胚芽発酵抽出物を食品素材等に利用しやすくなるからである。
尚、これらの脱脂用の溶媒は、1種のみを用いても良いし2種以上併用しても良い。
上記「発酵」の際に使用する微生物は特に限定されないが、麹菌、酵母、クエン酸菌、乳酸菌、および酢酸菌等を用いることができる。そして、これらのうち、麹菌が好ましい。
上記「麹菌」として、特に限定されないが、例えば、清酒用、焼酎用、泡盛用、味噌用もしくは醤油用の麹菌から選ばれる1以上のものを用いることができる。
例えば、 アスペルギルス・カワチ(Aspergillus kawachii)、アスペルギルス・アワモリ(Aspergillus awamori)、アスペルギルス・オリゼ(Aspergillus oryzae)、アスペルギルス・ソーヤ(Aspergillus sojae)、アスペルギルス・サイトイ(Aspergillus saitoi)、アスペルギルス・ウサミ(Aspergillus usamii)から選ばれる1以上のものである。発酵の温度は特に限定されないが、10〜60℃、更には20〜40℃、特に25〜35℃が好ましい。これらの範囲とすることにより、麹菌による発酵が進むのに最適な温度だからである。
また、発酵時間は、特に限定されず、1〜7日、更には、2〜4日行うことが好ましい。
The rice bran and/or rice germ is preferably defatted. This is because it is possible to obtain a composition containing a higher concentration of the active ingredient. This degreasing method is not particularly limited,
At this time, preferable degreasing solvents include n-hexane and acetone. In particular, it is preferable to use n-hexane as the degreasing solvent. This is because the extracted oil component can be used as an edible oil and the fermented rice germ extract can be easily used as a food material.
These degreasing solvents may be used alone or in combination of two or more.
The microorganism used in the "fermentation" is not particularly limited, but koji mold, yeast, citric acid bacterium, lactic acid bacterium, acetic acid bacterium and the like can be used. Of these, koji mold is preferable.
The above-mentioned "Koji mold" is not particularly limited, but for example, one or more selected from sake mold, shochu, awamori, miso or soy sauce can be used.
For example, Aspergillus kawachii, Aspergillus awamori, Aspergillus oryzae, Aspergillus sojae, Aspergillus saitoius, Aspergillus saitoi, Aspergillus saitoi One or more selected. The fermentation temperature is not particularly limited, but is preferably 10 to 60°C, more preferably 20 to 40°C, and particularly preferably 25 to 35°C. This is because the temperature within this range is the optimum temperature for the fermentation by the koji mold to proceed.
The fermentation time is not particularly limited, and it is preferably 1 to 7 days, more preferably 2 to 4 days.
「極性溶媒」として、水、メタノール、エタノール、イソプロピルアルコール、1,3−ブチレングリコール、エチレングリコール、プロピレングリコール、グリセリン、酢酸エチル等の極性溶媒を使用することができる。これらの溶媒を2種以上混合してもよい。
望ましくは、水エタノールまたはこれらの混合物である含水エタノールを抽出溶媒として用いると、有効成分が効率よく抽出される。
As the "polar solvent", polar solvents such as water, methanol, ethanol, isopropyl alcohol, 1,3-butylene glycol, ethylene glycol, propylene glycol, glycerin, ethyl acetate and the like can be used. You may mix 2 or more types of these solvents.
Desirably, when water ethanol or water-containing ethanol which is a mixture thereof is used as an extraction solvent, the active ingredient is efficiently extracted.
抽出溶媒としての含水エタノールを用いる場合、エタノールの濃度が特に限定されないが、特にエタノール濃度10〜90%(wt/wt)、望ましくはエタノール濃度20〜80%(wt/wt)であるとよい。エタノール濃度90%(wt/wt)以下としたのは、エタノール濃度が高すぎると、発酵抽出物の油分が含水エタノール中に溶け出しやすくなるからである。 When hydrous ethanol is used as the extraction solvent, the concentration of ethanol is not particularly limited, but the ethanol concentration is preferably 10 to 90% (wt/wt), and more preferably 20 to 80% (wt/wt). The reason why the ethanol concentration is 90% (wt/wt) or less is that if the ethanol concentration is too high, the oil component of the fermentation extract easily dissolves in the hydrous ethanol.
抽出温度としては、20〜80℃、望ましくは40〜50℃程度で行うとよい。抽出温度が低すぎると、有効成分が抽出されにくくなり、抽出温度が高すぎると、有効成分が分解し、生理活性(健康機能性)が低下するためである。 The extraction temperature is 20 to 80°C, preferably about 40 to 50°C. This is because if the extraction temperature is too low, the active ingredient becomes difficult to extract, and if the extraction temperature is too high, the active ingredient is decomposed and the physiological activity (health functionality) is reduced.
抽出方法としては、撹拌抽出、連続抽出、浸漬抽出、向流抽出、超臨界抽出など任意の方法を採用することができ、室温ないし還流加熱下において任意の装置を使用することができる。 As the extraction method, any method such as stirring extraction, continuous extraction, immersion extraction, countercurrent extraction, supercritical extraction can be adopted, and any apparatus can be used at room temperature or under reflux heating.
また、本発明は上記発酵抽出物をそのまま使用してもよいが、その発酵抽出物をその後、分液用極性溶媒で分配したものを使用することもできる。
上記「分配」の方法は特に限定されないが、液液分配を行うことが好ましい。液液分配で用いる溶媒は特に限定されず、例えば、水、メタノール、エタノール、イソプロピルアルコール、1,3−ブチレングリコール、エチレングリコール、プロピレングリコール、グリセリン、ヘキサン、酢酸エチル、クロロホルム等を用いることができ、これらのうち、ヘキサン、メタノール、クロロホルムを用いること好ましい。
Further, in the present invention, the above-mentioned fermentation extract may be used as it is, but it is also possible to use a product obtained by dividing the fermentation extract with a polar solvent for liquid separation thereafter.
The method of “distribution” is not particularly limited, but liquid-liquid distribution is preferable. The solvent used in the liquid-liquid distribution is not particularly limited, and for example, water, methanol, ethanol, isopropyl alcohol, 1,3-butylene glycol, ethylene glycol, propylene glycol, glycerin, hexane, ethyl acetate, chloroform and the like can be used. Of these, hexane, methanol and chloroform are preferably used.
上記方法によって、スティグマステロール、エルゴステロールパーオキサイド、β-シトステロールグルコシド、グルコシルセラミド等の化合物を得ることができるが、これらに限定されない。尚、これらは1種のみの化合物を単離したものを使用してもよいし、これらの混合物、或いは、クルードなものを用いてもよい。 By the above method, compounds such as stigmasterol, ergosterol peroxide, β-sitosterol glucoside, and glucosylceramide can be obtained, but are not limited thereto. In addition, these may use what isolate|separated only one type of compound, these mixtures, or a crude thing may be used.
また、本発明は、スティグマステロール、エルゴステロールパーオキサイド、β-シトステロールグルコシド、グルコシルセラミドのうちのいずれか1つを有効成分とすることを特徴とする。
上記化合物を得る方法は特に限定されないが、上述したように上記発酵物を精製、単離することによって得ることができる。
Further, the present invention is characterized in that any one of stigmasterol, ergosterol peroxide, β-sitosterol glucoside, and glucosylceramide is used as an active ingredient.
The method for obtaining the above compound is not particularly limited, but it can be obtained by purifying and isolating the above-mentioned fermented product as described above.
本発明は、様々な用途に適用することができる。用途として、医薬品、試薬、経口摂取用組成物(たとえば、健康食品、機能性表示食品、サプリメント、特定用途食品、及びペット用サプリメント等)が挙げられる。 The present invention can be applied to various uses. Examples of applications include pharmaceuticals, reagents, and compositions for oral ingestion (for example, health foods, foods with functional claims, supplements, foods for specific purposes, supplements for pets, etc.).
本発明を含む医薬組成物は、賦形剤、担体又は添加剤を含んでいてもよい。賦形剤、担体及び添加剤としては、通常使用され、かつ薬学的に許容されるものであれば特に限定されず、その種類及び組成は、適宜変更が可能である。 The pharmaceutical composition containing the present invention may contain an excipient, a carrier or an additive. Excipients, carriers, and additives are not particularly limited as long as they are commonly used and pharmaceutically acceptable, and their types and compositions can be appropriately changed.
賦形剤としては、塩化ナトリウム、クエン酸ナトリウム等が挙げられ、担体としては、滅菌水、生理食塩水、及び各種緩衝液等が挙げられる。添加剤としては、粘ちょう剤、緩衝材、保存剤、防腐剤等が挙げられる。 Examples of the excipient include sodium chloride, sodium citrate and the like, and examples of the carrier include sterilized water, physiological saline, various buffer solutions and the like. Examples of the additives include thickeners, buffers, preservatives, preservatives and the like.
医薬用組成物の剤型としては特に制限されるものではなく、必要に応じて適宜選択すればよいが、例えば、錠剤、カプセル剤、顆粒剤、細粒剤、散剤等の経口剤;注射剤、坐剤、
塗布剤等の非経口剤が挙げられる。
The dosage form of the pharmaceutical composition is not particularly limited and may be appropriately selected as necessary. For example, oral preparations such as tablets, capsules, granules, fine granules and powders; injections , Suppositories,
Parenteral agents such as a coating agent may be mentioned.
錠剤、カプセル剤、顆粒剤、細粒剤、散剤等の経口剤は、例えば、デンプン、乳糖、白糖、トレハロース、マンニット、カルボキシメチルセルロース、コーンスターチ、無機塩類等を用いて常法に従って製造される、これらの製剤中の本発明の化合物の配合量は特に限定されるものではなく、適宜設定することができる。この種の製剤には、結合剤、崩壊剤、界面活性剤、滑沢剤、流動性促進剤、矯味剤、着色剤、香料等を適宜使用することができる。 Oral preparations such as tablets, capsules, granules, fine granules, powders, etc. are manufactured according to a conventional method using starch, lactose, sucrose, trehalose, mannitol, carboxymethylcellulose, corn starch, inorganic salts, etc., The compounding amount of the compound of the present invention in these preparations is not particularly limited and can be appropriately set. Binders, disintegrants, surfactants, lubricants, fluidity promoters, corrigents, coloring agents, flavors and the like can be appropriately used in this type of preparation.
非経口剤の場合、患者の年齢、体重、疾患の程度等に応じて用量を調節し、例えば、静注、点滴静注、皮下注射、筋肉注射等によって投与する。この非経口剤は常法に従って製造され、希釈剤として一般に注射用蒸留水、生理食塩水等を用いることができる。さらに必要に応じて、殺菌剤、防腐剤、安定剤等を加えてもよい。また、この非経口剤は安定性の点から、バイアル等に充填後冷凍し、通常の凍結乾燥処理により水分を除き、使用直前に凍結乾燥物から液剤を再調製することもできる。さらに必要に応じて、張化剤、安定剤、防腐剤、無痛化剤等を加えてもよい。その他の非経口剤の例として、外用液剤、軟膏等の塗布剤、直腸内投与のための坐剤等が挙げられ、これらも常法に従って製造される。 In the case of a parenteral preparation, the dose is adjusted according to the age, body weight, degree of disease, etc. of the patient and administered by, for example, intravenous injection, intravenous drip injection, subcutaneous injection, intramuscular injection or the like. This parenteral preparation is manufactured according to a conventional method, and distilled water for injection, physiological saline or the like can be generally used as a diluent. Further, if necessary, a bactericide, a preservative, a stabilizer and the like may be added. Further, from the viewpoint of stability, this parenteral preparation may be filled in a vial or the like and then frozen, the water content thereof may be removed by an ordinary freeze-drying treatment, and the liquid preparation may be re-prepared from the freeze-dried product immediately before use. Further, if necessary, a tonicity agent, a stabilizer, a preservative, a soothing agent, etc. may be added. Examples of other parenteral agents include liquid preparations for external use, coating agents such as ointments, suppositories for rectal administration, and the like, which are also manufactured according to a conventional method.
本発明を健康食品(機能性表示食品、特定保健用食品、健康飲料及びサプリメントを含む)に用いる場合、各種健康食品の原材料として本発明の化合物を健康食品に添加したり、必要に応じてデキストリン、乳糖、デンプン等の賦形剤や香料、色素等とともにペレット、錠剤、顆粒等に加工したり、またゼラチン等で被覆してカプセルに成形加工して健康食品を製造することができる。 When the present invention is used for health foods (including functionally labeled foods, foods for specified health uses, health drinks and supplements), the compound of the present invention may be added to health foods as a raw material for various health foods, or dextrin may be added as necessary. A health food can be produced by processing into pellets, tablets, granules or the like together with excipients such as lactose, starch and the like, flavors, pigments or the like, or by coating with gelatin or the like and molding into capsules.
健康食品に配合される筋肉増強剤の配合割合は、該筋肉増強剤から期待される効果が得られるのであれば特に制限されないが、通常、1回あたりの摂取量が0.0001〜2000mg程度である。 The blending ratio of the muscle enhancing agent to be incorporated into the health food is not particularly limited as long as the effect expected from the muscle enhancing agent can be obtained, but usually, the intake amount is about 0.0001 to 2000 mg. is there.
これらの健康食品には、その種類に応じて種々の成分を配合することができ、例えば、ブドウ糖、果糖、ショ糖、マルトース、ソルビトール、ステビオサイド、コーンシロップ、乳糖、クエン酸、酒石酸、リンゴ酸、コハク酸、乳酸、L−アスコルビン酸、dl−α−トコフェロール、エリソルビン酸ナトリウム、グリセリン、プロピレングリコール、グリセリン脂肪酸エステル、ポリグリセリン脂肪酸エステル、ショ糖脂肪酸エステル、ソルビタン脂肪酸エステル、プロピレングリコール脂肪酸エステル、アラビアガム、カラギーナン、カゼイン、ゼラチン、ペクチン、寒天、ビタミンB類、ニコチン酸アミド、パントテン酸カルシウム、アミノ酸類、カルシウム塩類、色素、香料、保存剤等の食品素材を使用することができる。さらに、健康維持機能をもった筋肉増強剤には、他の抗酸化物質や健康食品素材などの配剤、例えば、抗酸化物質(還元型アスコルビン酸(ビタミンC)、ビタミンE、還元型グルタチン、トコトリエノール、ビタミンA誘導体、リコピン、ルテイン、アスタキサンチン、ゼアキサンチン、フコキサンチン、尿酸、ユビキノン、コエンザイムQ10、葉酸、ニンニクエキス、アリシン、セサミン、リグナン類、カテキン、イソフラボン、カルコン、タンニン類、フラボノイド類、クマリン、イソクマリン類、ブルーベリーエキス)、健康食品素材(V.(ビタミン)A、V.B1、V.B2、V.B6、V.B12、V.C、V.D、V.E、V.P、コリン、ナイアシン、パントテン酸、葉酸カルシウム、EPA、オリゴ糖、食物繊維、スクアレン、大豆レシチン、タウリン、ドナリエラ、プロテイン、オクタコサノール、DHA、卵黄レシチン、リノール酸、ラクトフェリン、マグネシウム、亜鉛、クロム、セレン 、カリウム、ヘム鉄、カキ肉エキス、キトサン、キチンオリゴ糖、コラーゲン、コンドロイチン、ウコン、カンゾウ、クコシ、ケイヒ、サンザシ、生姜、霊芝、シジミエキス、スッポン、カミツレ、カモミール、セイヨウタンポポ、ハイビスカス、ハチミツ、ボーレン、ローヤルゼリー、ライム、ラベンダー、ローズヒップ 、ローズマリー、ビフィズス菌、フェーカリス菌、ラクリス、小麦胚芽油、ゴマ油、シソ油、大豆油、中鎖脂肪酸、アガリクス、イチョウ葉エキス、ウコン、コンドロイチン、玄米胚芽エキス、レイシ、タマネギ、DPA、 甜茶、冬虫夏草、ニンニク、蜂の子、パパイヤ、プーアル、プロポリス、メグスリの木、ヤブシタケ、ノコギリヤシ、ヒアルロン酸、コラーゲン、ギャバ、ハープシールオイル、サメ軟骨、グルコサミン、レシチン、ホスファチジルセリン、田七ニンジン、桑葉、大豆抽出物、エキナセア、エゾウコギ、大麦抽出物、オリーブ葉、オリーブ実、ギムネマ、バナバ、サラシア、ガルシニア、キトサン、セントジョーンズワート、ナツメ、ニンジン、パッションフラワー、ブロッコリー、プラセンタ、ハトムギ、ブドウ種子、ピーナッツ種皮、ビルベリー、ブラックコホシュ、マリアアザミ、月桂樹、セージ、ラフマ、黒酢、ゴーヤー、マカ、紅花、亜麻、ウーロン茶、花棘、カフェイン、カプサイシン、キシロオリゴ糖、グルコサミン、ソバ、シトラス、食物繊維、プロテイン、プルーン、スピルリナ、大麦若葉、核酸、酵母、椎茸、梅肉、アミノ酸、深海鮫抽出物、ノニ、カキ肉、シャンピニオン、オオバコ、アセロラ、パイナップル、バナナ、モモ、アンズ、メロン、イチゴ、ラズベリー、オレンジ、フコイダン、メシマコブ、クランベリー、コンドロイチン硫酸、亜鉛、鉄、セラミド、シルクペプチド、グリシン、ナイアシン、チェストツリー、L-システイン、赤ワイン葉、ミレット、ホーステール、ビオチン、センテラアジアティカ、ハスカップ、ピクノジェノール、フキ、ルバーブ、クロ
ーブ、カテキン、プーアル、クエン酸、ビール酵母、メリロート、ブラックジンガー、ショウガ、ガジュツ、ナットウキナーゼ、ベニコウジ、トコトリエノール、ラクトフェリン、シナモン、韃靼ソバ、ココア、ユズ種子エキス、シソの実エキス、ライチ種子エキス、月見草エキス、黒米エキス、α−リポ酸、生コーヒー豆エキス、温州みかんエキス、トリテルペノイド、キウイ種子エキス、赤ショウガエキス、アスタキサンチン、クルミエキス、レスベラトロール、赤米エキス、白キクラゲ多糖体、イチゴ種子エキス、イチゴ種子エキス、ニラ種子エキス、リンゴンベリーエキス、桜の花エキス、ササクレヒトヨダケエキス、マキベリーエキス、米ポリアミン、小麦ポリアミン、黒ショウガエキス、ジュンサイエキス、ツバメの巣エキス、紫茶エキス、菊の花エキス、シーベリーエキス)なども配合することができる。
These health foods can be blended with various components depending on their types, for example, glucose, fructose, sucrose, maltose, sorbitol, stevioside, corn syrup, lactose, citric acid, tartaric acid, malic acid, Succinic acid, lactic acid, L-ascorbic acid, dl-α-tocopherol, sodium erythorbate, glycerin, propylene glycol, glycerin fatty acid ester, polyglycerin fatty acid ester, sucrose fatty acid ester, sorbitan fatty acid ester, propylene glycol fatty acid ester, gum arabic Food materials such as carrageenan, casein, gelatin, pectin, agar, vitamin Bs, nicotinic acid amide, calcium pantothenate, amino acids, calcium salts, pigments, flavors and preservatives can be used. Furthermore, muscle strengthening agents having a health maintenance function include other antioxidants and health food materials such as antioxidants (reduced ascorbic acid (vitamin C), vitamin E, reduced glutatin, tocotrienol). , Vitamin A derivative, lycopene, lutein, astaxanthin, zeaxanthin, fucoxanthin, uric acid, ubiquinone, coenzyme Q10, folic acid, garlic extract, allicin, sesamin, lignans, catechin, isoflavone, chalcone, tannins, flavonoids, coumarin, isocoumarin , Blueberry extract), health food ingredients (V. (vitamin) A, V.B1, V.B2, V.B6, V.B12, VC, VD, VE, VP, choline, niacin, pantothenic acid, calcium folate) , EPA, oligosaccharides, dietary fiber, squalene, soy lecithin, taurine, donariella, protein, octacosanol, DHA, egg yolk lecithin, linoleic acid, lactoferrin, magnesium, zinc, chromium, selenium, potassium, heme iron, oyster meat extract, chitosan , Chitin oligosaccharide, collagen, chondroitin, turmeric, liquorice, kokushi, keihi, hawthorn, ginger, ganoderma lucidum, clam extract, terrapin, chamomile, chamomile, dandelion, hibiscus, honey, boren, royal jelly, lime, lavender, rosehip, Rosemary, bifidobacteria, faecalis fungus, lacris, wheat germ oil, sesame oil, perilla oil, soybean oil, medium chain fatty acid, agarix, ginkgo biloba extract, turmeric, chondroitin, brown rice germ extract, litchi, onion, DPA, beetroot tea, caterpillar , Garlic, bee pup, papaya, puer, propolis, megusuri tree, yam mushroom, saw palmetto, hyaluronic acid, collagen, gaba, harp seal oil, shark cartilage, glucosamine, lecithin, phosphatidylserine, field carrot, mulberry leaf, soybean Extract, Echinacea, Eleuthero, barley extract, olive leaf, olive fruit, Gymnema, Banaba, Salacia, Garcinia, chitosan, St. John's wort, jujube, carrot, passion flower, broccoli, placenta, coix, grape seed, peanut seed coat, bilberry , Black cohosh, thistle, laurel, sage, rafuma, black vinegar, bitter melon, maca, safflower, flax, oolong tea, flower spines, caffeine, capsaicin, xylooligosaccharide, glucosamine, buckwheat, citrus, dietary fiber, Protein, prune, spirulina, barley leaf, nucleic acid, yeast, shiitake mushroom, plum meat, amino acid, deep sea shark extract, noni, oyster meat, champignon, plantain, acerola, pineapple, banana, peach, apricot, melon, strawberry, raspberry, Orange, Fucoidan, Phellinus linteus, Cranberry, Chondroitin Sulfate, Zinc, Iron, Ceramide, Silk Peptide, Glycine, Niacin, Chest Tree, L-Cysteine, Red Wine Leaf, Millet, Horsetail, Biotin, Centella Asiatica, Hascup, Pycnogenol, Butterbur, rhubarb, cloves, catechin, puer, citric acid, brewer's yeast, merrilot, black zinger, ginger, gadgets, nattokinase, benizi, tocotrienols, lactoferrin, cinnamon, Chinese barley buckwheat, cocoa, yuzu seed extract, perilla seed extract, litchi Seed extract, evening primrose extract, black rice extract, α-lipoic acid, green coffee bean extract, Satsuma mandarin orange extract, triterpenoid, kiwi seed extract, red ginger extract, astaxanthin, walnut extract, resveratrol, red rice extract, white fungus polysaccharide, Strawberry seed extract, strawberry seed extract, leek seed extract, lingonberry extract, cherry blossom extract, Pleurotus cornucopia extract, maqui berry extract, rice polyamine, wheat polyamine, black ginger extract, jungsai extract, swallow nest extract, purple tea extract. , Chrysanthemum flower extract, seaberry extract) and the like can also be added.
上記筋肉増強剤は、本発明を健康食品として使用する場合、その形態としては、各種一般飲食品の剤型として使用することができる。ここで「各種一般飲食品の剤型として使用することができる。」とは、上記筋肉増強剤としての効果を発揮することを目的として剤型とて一般飲食品を選択することができるという意味であり、筋肉増強剤から期待される効果を希望する人のみが食することを目的としており、上記筋肉増強剤としての効果を期待しない人をも含む広く万人に食することができるという意味ではない。
また、上記筋肉増強剤として効果を発揮するための配合量は特に限定されないが、飲食品に対して有効成分の含量が合計1〜20wt%であるのが好ましい。また、配合する一般飲食品として特に限定さないが、例えば、食用油(サラダ油)、菓子類(ガム、キャンディー、キャラメル、チョコレート、クッキー、スナック、ゼリー、グミ、錠菓等)、麺類(そば、うどん、ラーメン等)、乳製品(ミルク、アイスクリーム、ヨーグルト等)、調味料(味噌、醤油等)、スープ類、飲料(ジュース、コーヒー、紅茶、茶、炭酸飲料、スポーツ飲料等)等が挙げられる。
When the present invention is used as a health food, the muscle enhancing agent can be used in the form of various general foods and drinks. Here, "it can be used as a dosage form of various general foods and drinks." means that general foods and drinks can be selected as a dosage form for the purpose of exerting the effect as the muscle enhancing agent. Is intended to be eaten only by those who desire the effect expected from the muscle strengthening agent, and can be widely eaten by everyone including those who do not expect the effect as the muscle strengthening agent. is not.
Further, the compounding amount for exerting the effect as the muscle enhancing agent is not particularly limited, but it is preferable that the total content of the active ingredient is 1 to 20 wt% with respect to the food or drink. In addition, although it is not particularly limited as a general food or drink to be mixed, for example, edible oil (salad oil), confectionery (gum, candy, caramel, chocolate, cookie, snack, jelly, gummy, tablet confectionery, etc.), noodles (soba, soba, Udon, ramen, etc.), dairy products (milk, ice cream, yogurt, etc.), seasonings (miso, soy sauce, etc.), soups, drinks (juice, coffee, tea, tea, carbonated drinks, sports drinks, etc.), etc. Be done.
これら一般飲食品には、その種類に応じて種々の成分を配合することができ、例えば、ブドウ糖、果糖、ショ糖、マルトース、ソルビトール、ステビオサイド、コーンシロップ、乳糖、クエン酸、酒石酸、リンゴ酸、コハク酸、乳酸、L−アスコルビン酸、dl−α−トコフェロール、エリソルビン酸ナトリウム、グリセリン、プロピレングリコール、グリセリン脂肪酸エステル、ポリグリセリン脂肪酸エステル、ショ糖脂肪酸エステル、ソルビタン脂肪酸エステル、プロピレングリコール脂肪酸エステル、アラビアガム、カラギーナン、カゼイン、ゼラチン、ペクチン、寒天、ビタミンB類、ニコチン酸アミド、パントテン酸カルシウム、アミノ酸類、カルシウム塩類、色素、香料、保存剤等の食品素材を使用することができる。さらに、健康維持機能をもった上記筋肉増強剤には、他の抗酸化物質や健康食品素材などの配剤、例えば、抗酸化物質(還元型アスコルビン酸(ビタミンC)、ビタミンE、還元型グルタチン、トコトリエノール、ビタミンA誘導体、リコピン、ルテイン、アスタキサンチン、ゼアキサンチン、フコキサンチン、尿酸、ユビキノン、コエンザイムQ10、葉酸、ニンニクエキス、アリシン、セサミン、リグナン類、カテキン、イソフラボン、カルコン、タンニン類、フラボノイド類、クマリン、イソクマリン類、ブルーベリーエキス)、健康食品素材(V.(ビタミン)A、V.B1、V.B2、V.B6、V.B12、V.C、V.D、V.E、V.P、コリン、ナイアシン、パントテン酸、葉酸カルシウム、EPA、オリゴ糖、食物繊維、スクアレン、大豆レシチン、タウリン、ドナリエラ、プロテイン、オクタコサノール、卵黄レシチン、リノール酸、ラクトフェリン、マグネシウム、クロム、セレン、カリウム、ヘム鉄、カキ肉エキス、キトサン、キチンオリゴ糖、コラーゲン、コンドロイチン、ウコン、カンゾウ、クコシ、ケイヒ、サンザシ、生姜、霊芝、シジミエキス、カンゾウ、クコシ、ケイヒ、サンザシ、生姜、霊芝、オオバコ、カミツレ、カモミール、セイヨウタンポポ、ハイビスカス、ハチミツ、ボーレン、ローヤルゼリー、ライム、ラベンダー、ローズヒップ、ローズマリー、セージ、ビフィズス菌、フェーカリス菌、ラクリス、小麦胚芽油、ゴマ油、シソ油、大豆油、中鎖脂肪酸、アガリクス、イチョウ葉エキス、ウコン、コンドロイチン、玄米胚芽エキス、レイシ、タマネギ、DHA、 EPA、 DPA、甜茶、冬虫夏草、ニンニク、蜂の子、パパイヤ、プーアル、プロポリス、メグスリの木、ヤブシタケ、ロイヤルゼリー、ノコギリヤシ、ヒアルロン酸、コラーゲン、ギャバ、ハープシールオイル、サメ軟骨、グルコサミン、レシチン、ホスファチジルセリン、田七ニンジン、桑葉、大豆抽出物、エキナセア、エゾウコギ、大麦抽出物、オリーブ葉、オリーブ実、ギムネマ、バナバ、サラシア、ガルシニア、キトサン、セントジョーンズワート、ナツメ、ニンジン、パッションフラワー、ブロッコリー、プラセンタ、ハトムギ、ブドウ種子、ピーナッツ種皮、ビルベリー、ブラックコホシュ、マリアアザミ、月桂樹、セージ、ローズマリー、ラフマ、黒酢、ゴーヤー、マカ、紅花、亜麻、ウーロン茶、花棘、カフェイン、カプサイシン、キシロオリゴ糖、グルコサミン、ソバ、シトラス、食物繊維、プロテイン、プルーン、スピルリナ、大麦若葉、核酸、酵母、椎茸、梅肉、アミノ酸、深海鮫抽出物、ノニ、カキ肉、スッポン、シャンピニオン、オオバコ、アセロラ、パイナップル、バナナ、モモ、アンズ、メロン、イチゴ、ラズベリー、オレンジ、フコイダン、メシマコブ、クランベリー、コンドロイチン硫酸、亜鉛、鉄、セラミド、シルクペプチド、グリシン、ナイアシン、チェストツリー、L-システイン、赤ワイン葉、ミレット、ホーステール、ビオチン、センテラアジアティカ、ハスカップ、ピクノジェノール、フキ、ルバーブ、クローブ、ローズマリー、カテキン、プーアル、クエン酸、ビール酵母、メリロート、ブラックジンガー、ショウガ、ガジュツ、ナットウキナーゼ、ベニコウジ、トコトリエノール、ラクトフェリン、シナモン、韃靼ソバ、ココア、ユズ種子エキス、シソの実エキス、ライチ種子エキス、月見草エキス、黒米エキス、α−リポ酸、ギャバ、生コーヒー豆エキス、フキエキス、キウイ種子エキス、温州みかんエキス、アカショウガエキス、アスタキサンチン、クルミエキス、ニラ種子エキス、赤米エキス、カンカエキス、白キクラゲ多糖体、フコキサンチン、リンゴンベリーエキス、桜の花エキス、マキベリーエキス、ササクレヒトヨタケエキス、米ポリアミン、小麦ポリアミン、黒ショウガエキス、ジュンサイエキス、ツバメの巣エキス、紫茶エキス、菊の花エキス、シーベリーエキス)なども配合することができる。 These general foods and drinks can be blended with various components depending on their types, for example, glucose, fructose, sucrose, maltose, sorbitol, stevioside, corn syrup, lactose, citric acid, tartaric acid, malic acid, Succinic acid, lactic acid, L-ascorbic acid, dl-α-tocopherol, sodium erythorbate, glycerin, propylene glycol, glycerin fatty acid ester, polyglycerin fatty acid ester, sucrose fatty acid ester, sorbitan fatty acid ester, propylene glycol fatty acid ester, gum arabic Food materials such as carrageenan, casein, gelatin, pectin, agar, vitamin Bs, nicotinic acid amide, calcium pantothenate, amino acids, calcium salts, pigments, flavors and preservatives can be used. In addition, the muscle enhancing agent having a health maintenance function includes other antioxidants and health food materials such as antioxidants (reduced ascorbic acid (vitamin C), vitamin E, reduced glutatin, Tocotrienols, vitamin A derivatives, lycopene, lutein, astaxanthin, zeaxanthin, fucoxanthin, uric acid, ubiquinone, coenzyme Q10, folic acid, garlic extract, allicin, sesamin, lignans, catechins, isoflavones, chalcones, tannins, flavonoids, coumarin, Isocoumarins, blueberry extract), health food materials (V. (vitamins) A, V.B1, V.B2, V.B6, V.B12, VC, VD, VE, VP, choline, niacin, pantothenic acid, folic acid Calcium, EPA, oligosaccharide, dietary fiber, squalene, soy lecithin, taurine, donariella, protein, octacosanol, egg yolk lecithin, linoleic acid, lactoferrin, magnesium, chromium, selenium, potassium, heme iron, oyster meat extract, chitosan, chitin oligo Sugar, collagen, chondroitin, turmeric, licorice, kokushi, cinnamon beetle, hawthorn, ginger, ganoderma lucidum, hydrangea extract, kanzo, kokushi, keihi, hawthorn, ginger, ganoderma lucidum, psyllium, chamomile, chamomile, dandelion, hibiscus, honey, boren , Royal jelly, lime, lavender, rosehip, rosemary, sage, bifidobacteria, faecalis fungus, lacris, wheat germ oil, sesame oil, perilla oil, soybean oil, medium chain fatty acid, agarix, ginkgo biloba extract, turmeric, chondroitin, brown rice Germ extract, litchi, onion, DHA, EPA, DPA, beet tea, caterpillar, garlic, bee pup, papaya, puer, propolis, megusuri tree, yab mushroom, royal jelly, saw palmetto, hyaluronic acid, collagen, gaba, harp seal oil , Shark cartilage, glucosamine, lecithin, phosphatidylserine, field carrot, mulberry leaf, soybean extract, echinacea, eleuthero, barley extract, olive leaf, olive fruit, gymnema, banaba, salacia, garcinia, chitosan, St. John's wort, jujube , Carrot, passionflower, broccoli, placenta, pearl barley, grape seeds, peanut seed coat, bilberry, black cohosh, maria thistle, laurel, sage, rosemary, rafuma, black vinegar, bitter melon, maca, safflower, flax, u -Long tea, flower spines, caffeine, capsaicin, xylooligosaccharide, glucosamine, buckwheat, citrus, dietary fiber, protein, prune, spirulina, barley leaf, nucleic acid, yeast, shiitake mushroom, plum meat, amino acid, deep sea shark extract, noni, Oyster meat, soft-shelled turtle, champignon, plantain, acerola, pineapple, banana, peach, apricot, melon, strawberry, raspberry, orange, fucoidan, messimacob, cranberry, chondroitin sulfate, zinc, iron, ceramide, silk peptide, glycine, niacin, chest Tree, L-cysteine, red wine leaf, millet, horsetail, biotin, centella asiatica, haskap, pycnogenol, butterbur, rhubarb, clove, rosemary, catechin, puer, citric acid, brewer's yeast, meliloth, black zinger, ginger , Gautu, Nattokinase, Benikouji, Tocotrienol, Lactoferrin, Cinnamon, Buckwheat buckwheat, Cocoa, Yuzu seed extract, Perilla seed extract, Litchi seed extract, Evening primrose extract, Black rice extract, α-lipoic acid, Gaba, Green coffee bean extract, Japanese butterbur extract , Kiwi seed extract, Wenzhou tangerine extract, red ginger extract, astaxanthin, walnut extract, leek seed extract, red rice extract, citrus extract, white fungus, polysaccharides, fucoxanthin, lingonberry extract, cherry blossom extract, maquiberry extract, sacred cherry extract. , Rice polyamine, wheat polyamine, black ginger extract, Junsai extract, swallow's nest extract, purple tea extract, chrysanthemum flower extract, seaberry extract) and the like can also be blended.
具体的な製法としては、上記筋肉増強剤を粉末セルロースとともにスプレードライまたは凍結乾燥し、これを粉末、顆粒、打錠または溶液にすることで容易に飲食品(健康食品、機能性表示食品等をも含む)等含有させることができる。また、上記筋肉増強剤を、例えば、油脂、エタノール、グリセリンあるいはこれらの混合物に溶解して液状にし、飲料に添加するか、固形食品に添加することが可能である。必要に応じてアラビアガム、デキストリン等のバインダーと混合して粉末状あるいは顆粒状にし、飲料に添加するか固形食品に添加することも可能である。 As a specific manufacturing method, the muscle enhancing agent is spray-dried or freeze-dried together with powdered cellulose, and the powder, granules, tableting or solution is used to easily prepare food and drink (health foods, foods with functional claims, etc. Can be included). In addition, the muscle enhancing agent can be dissolved in, for example, fats and oils, ethanol, glycerin, or a mixture thereof to form a liquid and then added to a beverage or a solid food. If necessary, it may be mixed with a binder such as gum arabic or dextrin to give a powder or granules, which may be added to a beverage or a solid food.
実施例:米胚芽発酵抽出物及び有効成分の単離
(1)米胚芽発酵抽出物の調製
脱脂米胚芽1.4 kgと等量の蒸留水を混合し、オートクレーブ滅菌したものに560 mgの麹菌および香煎42 gを加えて混合したものを35℃の条件下で3日間発酵させ、麹菌発酵米胚芽を得た。この発酵米胚芽を3 kgのメタノールでの加温抽出を3回行い、抽出液を減圧濃縮することにより156.06 gのメタノール抽出液(米胚芽発酵抽出物)を得た。
(2)有効成分の単離
このメタノール抽出液 83 gをヘキサン、酢酸エチル、クロロホルム:メタノール=6:1で順次分液を行い、ヘキサン可溶部17.67 g、酢酸エチル可溶部5.73 g、クロメタ可溶部3.73 gを得た。それぞれの可溶部を図1の分画スキームに従って分画を行い、Compound 1-5の5成分を単離した。単離した5成分についてNMRによる構造解析を行った。これらのうち、Compound 1、2、4、5について構造解析を行った。
ここで、上記Compound 1、2、4、5の化学式を以下に示す。
Example: Isolation of rice germ fermented extract and active ingredient (1) Preparation of rice germ fermented extract 1.4 kg of defatted rice germ and an equal amount of distilled water were mixed and autoclaved, and 560 mg of koji mold and incense 42 g was added and mixed, and the mixture was fermented at 35° C. for 3 days to obtain a koji mold fermented rice germ. The fermented rice germ was extracted with 3 kg of methanol with heating three times, and the extract was concentrated under reduced pressure to obtain 156.06 g of a methanol extract (fermented rice germ extract).
(2) Isolation of active ingredient 83 g of this methanol extract was sequentially separated with hexane, ethyl acetate, and chloroform:methanol = 6:1 to give 17.67 g of hexane-soluble portion, 5.73 g of ethyl acetate-soluble portion, and chrometa. 3.73 g of a soluble part was obtained. Each soluble part was fractionated according to the fractionation scheme of FIG. 1 to isolate 5 components of Compound 1-5. Structural analysis by NMR was performed on the five isolated components. Of these, structural analysis was performed on Compounds 1, 2, 4, and 5.
Here, the chemical formulas of Compounds 1, 2, 4, and 5 are shown below.
試験例1:筋分化誘導促進作用
(1)米胚芽発酵抽出物における試験
マウス筋芽細胞C2C12に対して米胚芽発酵抽出物を1-100μg/mLの濃度で添加し、それと同時に分化誘導を行った。1週間培養した後、細胞を回収し、筋早熟分化マーカーであるmyogeninと筋成熟分化マーカーmyosin, heavy polypeptide(MyHP)のmRNA発現量を定量解析した。その際、内因性コントロールとしてGAPDHを使用し補正した。尚、比較例として、発酵工程を有さない米抽出物及び発酵工程がない米由来タンパクであるオリザプロテイン(オリザ油化株式会社製)についても同様の試験を行った。その結果を図2に示す。
(2)単離成分における試験
上記方法と同様にして、米胚芽発酵エキスより単離した成分(Compound. 1-5)について1及び10μg/mLの濃度で試験を行った。その結果を図3(myogenin)及び図4(MyHP)に示す。
Test Example 1: Muscle Differentiation Induction Promoting Action (1) Test on Rice Germ Fermented Extract The rice germ fermented extract was added to mouse myoblast C2C12 at a concentration of 1-100 μg/mL, and at the same time, differentiation was induced. It was After culturing for 1 week, the cells were collected and quantitatively analyzed for the mRNA expression levels of myogenin which is a muscle precocious differentiation marker and myosin, heavy polypeptide (MyHP). At that time, GAPDH was used as an endogenous control for correction. In addition, as a comparative example, the same test was conducted on rice extract having no fermentation step and oryza protein (manufactured by Oryza Yuka Co., Ltd.) which is a rice-derived protein having no fermentation step. The result is shown in FIG.
(2) Test on isolated component In the same manner as the above method, the component (Compound. 1-5) isolated from the fermented rice germ extract was tested at a concentration of 1 and 10 µg/mL. The results are shown in Fig. 3 (myogenin) and Fig. 4 (MyHP).
試験例1における実施例の効果
図2に示されるように、米胚芽発酵抽出物によって有意に筋細胞増殖が促進した。また、ポジティブコントロールであるIGF-1も有意に増殖した。また、未発酵米胚芽エキスでは細胞増殖を抑制する作用が見られ、発酵を行っていない米抽出物である米由来タンパク質(オリザプロテイン)では、筋増殖促進効果は米胚芽発酵エキスと比較して弱かった。以上のことから、米胚芽を発酵することで今までにはなかった筋肉増強効果を得ることができ、それはタンパク質を摂取するよりも強いことが確認された。
また、図3に示すように、筋早熟分化マーカーであるmyogeninにおいてCompound 1-5(1および10 μg/mL)の添加によって発現が促進した。特に、Compound 1(1μg/mL)及びCompound 5(1および10 μg/mL)の添加で有意に発現が促進した。一方で、図4示すように、筋成熟分化マーカーであるMyHPにおいてCompound 1(1および10 μg/mL)、Compound 3(10 μg/mL)、Compound 4(1 μg/mL)、Compound 5(1および10 μg/mL)の添加によって発現が促進した。特に、Compound 1(1μg/mL)及びCompound 5(10 μg/mL)の添加で有意に発現が促進した。以上のことから、Compound 1-5には早熟期及び成熟期の筋分化誘導を促進する活性があることが確認された。以上により、米胚芽発酵エキス及びCompound 1-5は筋分化誘導促進剤として機能することが確認された。
Effect of Example in Test Example 1 As shown in FIG. 2, the rice germ fermented extract significantly promoted myocyte proliferation. The positive control IGF-1 also proliferated significantly. In addition, unfermented rice germ extract has an action of suppressing cell growth, and rice-derived protein (Oryza protein), which is a non-fermented rice extract, has a muscle growth promoting effect as compared with the rice germ fermented extract. It was weak. From the above, it has been confirmed that fermenting rice germ has an unprecedented muscle-enhancing effect, which is stronger than ingesting protein.
Further, as shown in FIG. 3, the expression of myogenin, which is a muscle precocious differentiation marker, was promoted by the addition of Compound 1-5 (1 and 10 μg/mL). In particular, the addition of Compound 1 (1 μg/mL) and Compound 5 (1 and 10 μg/mL) significantly promoted the expression. On the other hand, as shown in FIG. 4, in MyHP which is a marker for differentiation of muscle maturation, Compound 1 (1 and 10 μg/mL), Compound 3 (10 μg/mL), Compound 4 (1 μg/mL), Compound 5 (1 And 10 μg/mL) promoted the expression. In particular, the addition of Compound 1 (1 μg/mL) and Compound 5 (10 μg/mL) significantly promoted the expression. From the above, it was confirmed that Compound 1-5 has an activity of promoting the induction of muscle differentiation in the precocious stage and the mature stage. From the above, it was confirmed that the fermented rice germ extract and Compound 1-5 function as a muscle differentiation induction promoter.
試験例2:筋細胞増殖促進作用(筋量増大作用)
(1)米発酵米胚芽抽出物による評価
マウス筋芽細胞C2C12に対して米発酵米胚芽抽出物、比較例として米由来タンパク質(オリザプロテイン)を1-100μg/mLで添加し、それと同時に分化誘導を行った。1週間培養した後、MTTアッセイを行い、細胞増殖に及ぼす影響を評価した。尚、比較例として、発酵工程を有さない米抽出物及び発酵工程がない米由来タンパクであるオリザプロテイン(オリザ油化株式会社製)についても同様の試験を行った。その結果を図5に示す。
(2)単離成分による評価
マウス筋芽細胞C2C12に対して米胚芽発酵エキス及び米胚芽発酵エキスより単離した成分(Compound 1)を0.1-30μg/mLの濃度で添加し、それと同時に分化誘導を行った。1週間培養した後、MTTアッセイを行い、細胞増殖に及ぼす影響を評価した。その結果を図6に示す。
Test Example 2: Muscle cell proliferation promoting action (muscle mass increasing action)
(1) Evaluation by rice fermented rice germ extract To the mouse myoblast C2C12, rice fermented rice germ extract, as a comparative example, rice-derived protein (Oriza protein) was added at 1-100 μg/mL, and at the same time, differentiation induction I went. After culturing for 1 week, MTT assay was performed to evaluate the effect on cell proliferation. In addition, as a comparative example, the same test was conducted on rice extract having no fermentation step and oryza protein (manufactured by Oryza Yuka Co., Ltd.) which is a rice-derived protein having no fermentation step. The result is shown in FIG.
(2) Evaluation by isolated components Rice germ fermented extract and component (Compound 1) isolated from rice germ fermented extract were added to mouse myoblast C2C12 at a concentration of 0.1-30 μg/mL, and at the same time differentiation induction I went. After culturing for 1 week, MTT assay was performed to evaluate the effect on cell proliferation. The result is shown in FIG.
試験例2における実施例の効果
図5に示されるように、米胚芽発酵抽出物によって有意に筋細胞増殖が促進した。また、ポジティブコントロールであるIGF-1も有意に増殖した。また、未発酵米胚芽エキスでは細胞増殖を抑制する作用が見られ、米由来タンパク質では、筋増殖促進効果は米胚芽発酵エキスと比較して弱かった。以上のことから、米胚芽を発酵することで今までにはなかった筋肉増強効果を得ることができ、それはタンパク質を摂取するよりも強いことが確認された。
また、図6に示すように、Compound 1を3~30 μg/mLの濃度で添加することで細胞増殖が有意に増加した。また、ポジティブコントロールである米胚芽発酵エキス(10 μg/mL)も有意に増加した。以上のことから、米胚芽発酵エキス及びその成分であるCompound 1は筋細胞の増殖を促進する活性があることが示唆された。以上により米胚芽発酵エキス及びその成分であるCompound 1は筋量増大剤として有用であることが確認された。
Effect of Example in Test Example 2 As shown in FIG. 5, the rice germ fermented extract significantly promoted myocyte proliferation. In addition, the positive control IGF-1 also proliferated significantly. In addition, the unfermented rice germ extract showed an action of suppressing cell growth, and the protein derived from rice had a weaker muscle growth promoting effect than the fermented rice germ extract. From the above, it was confirmed that fermenting rice germ had an unprecedented muscle-enhancing effect, which was stronger than ingesting protein.
Moreover, as shown in FIG. 6, cell proliferation was significantly increased by adding Compound 1 at a concentration of 3 to 30 μg/mL. The positive control rice fermented extract (10 μg/mL) also increased significantly. From the above, it was suggested that the rice germ fermented extract and its component Compound 1 have the activity of promoting the proliferation of muscle cells. From the above, it was confirmed that the fermented rice germ extract and its component Compound 1 are useful as a muscle mass increasing agent.
試験例3:筋肥大促進因子IGF-1発現促進活性
マウス筋芽細胞C2C12に対して米胚芽発酵エキスより単離した成分(Compound 1-5)を1及び10μg/mLの濃度で添加し、それと同時に分化誘導を行った。1週間培養した後、細胞を回収し、筋肉増量因子IGF-1のmRNA発現量を定量解析した。その際、内因性コントロールとしてGAPDHを使用し補正した。その結果を図7に示す。
Test Example 3: Muscle hypertrophy promoting factor IGF-1 expression promoting activity To the mouse myoblast C2C12, the components (Compound 1-5) isolated from the rice germ fermentation extract were added at a concentration of 1 and 10 μg/mL, and At the same time, differentiation was induced. After culturing for 1 week, the cells were collected and quantitatively analyzed for the mRNA expression level of the muscle growth factor IGF-1. At that time, GAPDH was used as an endogenous control for correction. The result is shown in FIG. 7.
試験例3における実施例の効果
図7に示すように、筋肉増量因子であるIGF-1においてCompound 1(1μg/mL)及びCompound 5(1 μg/mL)の添加で発現が促進した。以上のことから、Compound 1及び5は筋肉増量遺伝子発現促進剤として有用であることが確認された。
Effects of Examples in Test Example 3 As shown in FIG. 7, the expression of IGF-1, which is a muscle mass increasing factor, was promoted by the addition of Compound 1 (1 μg/mL) and Compound 5 (1 μg/mL). From the above, Compound 1 and 5 were confirmed to be useful as a muscle mass increasing gene expression promoter.
試験例4:筋収縮促進作用
コラーゲンゲルに包埋したマウス筋芽細胞C2C12に対して米胚芽発酵エキス(10μg/ml)及びCompound 5(10μg/ml)、インスリン様成長因子1(IGF-1、1 ng/ml)を添加し、それと同時に分化誘導を行った。2週間分化誘導を行った後、コラーゲンゲルの大きさを測定し収縮力に及ぼす影響を評価した。その結果を図8に示す。
Test Example 4: Muscle contraction promoting action For mouse myoblast C2C12 embedded in collagen gel, rice germ fermentation extract (10 μg/ml) and Compound 5 (10 μg/ml), insulin-like growth factor 1 (IGF-1, 1 ng/ml) was added, and at the same time, differentiation was induced. After inducing differentiation for 2 weeks, the size of the collagen gel was measured and the effect on the contractile force was evaluated. The result is shown in FIG.
試験例4における実施例の効果
筋収縮の指標としてコラーゲンゲル収縮試験を行った。その結果、図8に示すように、ポジティブコントロールであるIGF-1と同様に米胚芽発酵エキス及びCompound 5の添加によって有意にコラーゲンゲルの収縮が認められた。以上のことから、Compound 5には筋収縮力向上剤として有用であることが確認された。
Effect of Example in Test Example 4 A collagen gel contraction test was performed as an index of muscle contraction. As a result, as shown in FIG. 8, the contraction of collagen gel was significantly recognized by the addition of the rice germ fermentation extract and Compound 5 as in the positive control IGF-1. From the above, it was confirmed that Compound 5 is useful as a muscle contraction strength improving agent.
実施例の効果
以上により、米胚芽発酵エキス及びそれにより得られたCompound 1-5は筋肉増強剤として有用であることが確認された。
Effects of Examples From the above, it was confirmed that the fermented rice germ extract and Compound 1-5 obtained thereby are useful as a muscle strengthening agent.
本発明の筋肉増強剤の配合例を以下に示すが、下記配合例は本発明を限定するものではない。
配合例1:チューインガム(機能性表示食品又は特定保健用食品)
砂糖 53.0wt%
ガムベース 20.0
グルコース 10.0
水飴 16.0
香料 0.5
筋肉増強剤 0.5
100.0wt%
The formulation examples of the muscle enhancing agent of the present invention are shown below, but the following formulation examples do not limit the present invention.
Formulation 1: Chewing gum (food with functional claims or food for specified health uses)
Sugar 53.0wt%
Gum base 20.0
Glucose 10.0
Starch syrup 16.0
Fragrance 0.5
Muscle enhancer 0.5
100.0 wt%
配合例2:グミ(機能性表示食品又は特定保健用食品)
還元水飴 40.0wt%
グラニュー糖 20.0
ブドウ糖 20.0
ゼラチン 4.7
水 9.68
キウイ果汁 4.0
キウイフレーバー 0.6
色素 0.02
筋肉増強剤 1.0
100.0wt%
Formulation 2: Gummy (food with functional claims or food for specified health uses)
Reduced starch syrup 40.0wt%
Granulated sugar 20.0
Glucose 20.0
Gelatin 4.7
Water 9.68
Kiwi juice 4.0
Kiwi flavor 0.6
Pigment 0.02
Muscle enhancer 1.0
100.0 wt%
配合例3:キャンディー(機能性表示食品又は特定保健用食品)
砂糖 50.0wt%
水飴 33.0
水 14.4
有機酸 2.0
香料 0.2
筋肉増強剤 0.4
100.0wt%
Formulation 3: Candy (food with functional claims or food for specified health uses)
Sugar 50.0wt%
Starch syrup 33.0
Water 14.4
Organic acid 2.0
Fragrance 0.2
Muscle enhancer 0.4
100.0 wt%
配合例4:ヨーグルト(ハード・ソフト)(機能性表示食品又は特定保健用食品)
牛乳 41.5wt%
脱脂粉乳 5.8
砂糖 8.0
寒天 0.15
ゼラチン 0.1
乳酸菌 0.005
筋肉増強剤 0.4
香料 微量
水 残余
100.0wt%
Formulation 4: Yogurt (hard/soft) (food with functional claims or food for specified health uses)
Milk 41.5wt%
Skim milk powder 5.8
Sugar 8.0
Agar 0.15
Gelatin 0.1
Lactic acid bacteria 0.005
Muscle enhancer 0.4
Fragrance
Water residue
100.0 wt%
配合例5:清涼飲料(機能性表示食品又は特定保健用食品)
果糖ブドウ糖液糖 30.0wt%
乳化剤 0.5
筋肉増強剤 0.05
香料 適量
精製水 残余
100.0wt%
Formulation 5: Soft drink (food with functional claims or food for specified health use)
Fructose glucose liquid sugar 30.0 wt%
Emulsifier 0.5
Muscle enhancer 0.05
Fragrance suitable amount
Purified water residue
100.0 wt%
配合例6:ソフトカプセル(機能性表示食品又は特定保健用食品)
米胚芽油 87.0wt%
乳化剤 12.0
筋肉増強剤 1.0
100.0wt%
Formulation 6: Soft capsules (foods with functional claims or foods for specified health uses)
Rice germ oil 87.0 wt%
Emulsifier 12.0
Muscle enhancer 1.0
100.0 wt%
配合例7:錠剤(機能性表示食品又は特定保健用食品)
乳糖 54.0wt%
結晶セルロース 30.0
澱粉分解物 10.0
グリセリン脂肪酸エステル 5.0
筋肉増強剤 1.0
100.0wt%
Formulation 7: Tablets (foods with functional claims or foods for specified health uses)
Lactose 54.0wt%
Crystalline cellulose 30.0
Starch degradation product 10.0
Glycerin fatty acid ester 5.0
Muscle enhancer 1.0
100.0 wt%
配合例8:顆粒内服剤(医薬品)
筋肉増強剤 1.0wt%
乳糖 30.0
コーンスターチ 60.0
結晶セルロース 8.0
ポリビニールピロリドン 1.0
100.0wt%
Formulation 8: Oral granule (medicine)
Muscle enhancer 1.0 wt%
Lactose 30.0
Corn starch 60.0
Crystalline cellulose 8.0
Polyvinyl pyrrolidone 1.0
100.0 wt%
配合例9:錠菓
砂糖 76.4wt%
グルコース 19.0
ショ糖脂肪酸エステル 0.2
筋肉増強剤 0.5
精製水 3.9
100.0wt%
Formulation 9: Tablets
Sugar 76.4 wt%
Glucose 19.0
Sucrose fatty acid ester 0.2
Muscle enhancer 0.5
Purified water 3.9
100.0 wt%
配合例15:キャットフード
とうもろこし 34.0wt%
小麦粉 35.0
ミートミール 15.0
牛脂 8.9
食塩 1.0
かつおエキス 4.0
筋肉増強剤 1.0
タウリン 0.1
ビタミン類 0.5
ミネラル類 0.5
100.0wt%
Formulation 15: Cat food
Corn 34.0wt%
Flour 35.0
Meat meal 15.0
Beef tallow 8.9
Salt 1.0
Skipjack extract 4.0
Muscle enhancer 1.0
Taurine 0.1
Vitamins 0.5
Minerals 0.5
100.0 wt%
配合例16:ドッグフード
とうもろこし 30.0wt%
肉類(チキン) 15.0
脱脂大豆 10.0
小麦粉 25.0
糟糠類 5.0
筋肉増強剤 5.0
動物性油脂 8.9
オリゴ糖 0.1
ビタミン 0.5
ミネラル 0.5
100.0wt%
Formulation 16: dog food
Corn 30.0 wt%
Meat (chicken) 15.0
Defatted soybean 10.0
Flour 25.0
Rice bran 5.0
Muscle enhancer 5.0
Animal fats and oils 8.9
Oligosaccharide 0.1
Vitamin 0.5
Mineral 0.5
100.0 wt%
以上、説明したように、本発明は、新規な筋肉増強剤を提供することができる。
As described above, the present invention can provide a novel muscle enhancing agent.
Claims (5)
A muscle strengthening agent comprising the agent according to any one of claims 1 to 4 as an active ingredient.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2020030484A JP2020079309A (en) | 2020-02-26 | 2020-02-26 | Muscle-enhancing agent |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2020030484A JP2020079309A (en) | 2020-02-26 | 2020-02-26 | Muscle-enhancing agent |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2016083486A Division JP2017193497A (en) | 2016-04-19 | 2016-04-19 | Muscle-enhancing agent |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2021014102A Division JP7104193B2 (en) | 2021-02-01 | 2021-02-01 | Muscle builders |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2020079309A true JP2020079309A (en) | 2020-05-28 |
Family
ID=70801455
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2020030484A Pending JP2020079309A (en) | 2020-02-26 | 2020-02-26 | Muscle-enhancing agent |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2020079309A (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008156294A (en) * | 2006-12-25 | 2008-07-10 | Lion Corp | Myoblast activator |
JP2013181031A (en) * | 2012-02-29 | 2013-09-12 | Fukuyama Komezu:Kk | Testosterone secretion promotor, antifatigue agent, method for producing the same and use thereof |
-
2020
- 2020-02-26 JP JP2020030484A patent/JP2020079309A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008156294A (en) * | 2006-12-25 | 2008-07-10 | Lion Corp | Myoblast activator |
JP2013181031A (en) * | 2012-02-29 | 2013-09-12 | Fukuyama Komezu:Kk | Testosterone secretion promotor, antifatigue agent, method for producing the same and use thereof |
Non-Patent Citations (5)
Title |
---|
BIOL PHARM BULL, vol. 34(3), JPN6020050231, 2011, pages 318 - 323, ISSN: 0004415894 * |
CHEM. BIODIVERSITY, vol. 14, JPN6021029863, 2017, pages 1600175, ISSN: 0004699250 * |
FITOTERAPIA, vol. 98, JPN6020050233, 2014, pages 98 - 103, ISSN: 0004415895 * |
J. REPROD.DEV., vol. 49, JPN6021029864, 2003, pages 175 - 180, ISSN: 0004699249 * |
日本内分泌学会雑誌, vol. 88(2), JPN6020050229, 2012, pages 705, ISSN: 0004415893 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101700016B1 (en) | A muscle atrophy inhibitor | |
JPWO2006059730A1 (en) | Composition for reducing body fat | |
JP2013241354A (en) | Phosphodiesterase 2 inhibitor | |
US20200360338A1 (en) | Method for activating energy metabolism in muscle cells by administering to human beings at least one active substance comprising methoxyflavone | |
JP6086953B2 (en) | AMPK activator | |
JP2008239619A (en) | Peripheral blood circulation ameliorative composition | |
KR101320738B1 (en) | The method of extracting carotinoid pigments of micro algae and composition comprising the extracted fucoxanthin for preventing or treating obesity or diabetes | |
US20040219238A1 (en) | Remedies | |
JP2006083151A (en) | Composition for preventing and ameliorating osteoporosis | |
JP2020128436A (en) | Bone fortifier dietary supplements | |
KR101709281B1 (en) | Composition for Prevention or Treatment of Osteoporosis Comprising Herbal Extract and Fermentation Product thereof with Lactic acid Bacteria | |
JP2017193497A (en) | Muscle-enhancing agent | |
JP2016124832A (en) | Energy metabolism activator in muscle cells | |
KR20210080182A (en) | Composition for preventing and treating of obesity comprising powder of lactic acid cell lysate | |
JP2009269832A (en) | Calcitonin gene-related peptide and composition for accelerating production of insulin-like growth factor-1 | |
JP7104193B2 (en) | Muscle builders | |
JP6954960B2 (en) | TNF-α and IL-6 production inhibitors and muscle inflammation inhibitors using them | |
JP2007230881A (en) | Anti-fatigue composition | |
JP2020079309A (en) | Muscle-enhancing agent | |
JP2017031120A (en) | TNF-α AND IL-6 PRODUCTION INHIBITORS, AND MUSCLE INFLAMMATORY INHIBITORS USING THE SAME | |
KR20140106058A (en) | Composition for enhancing immunological activity comprising soluble salmon milt extract and vegetable lactic acid bacteria | |
JP2012006905A (en) | Composition for skin care | |
KR101344564B1 (en) | Composition comprising extract of hot peppers and Chinese peppers for preventing or treating of obesity or hyperlipidemia | |
KR20210085627A (en) | Composition for Enhancing Immunity Comprising Complex Extracts of Gryllus bimaculatus and Tenebrio molitor Linnaues as Active Ingredient | |
TW201424743A (en) | Igf-1 production promoter |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20200226 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20210106 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210201 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20210802 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20210914 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20220204 |